Barcelona Alzheimer Treatment & Research Center

publicacions científiques

2017

 

Impact Factor: 28.853                                                                   Total pub.:  3

Printed: 3.92 | E-pub: 24.933

Updated 31 mai 17

 

Sembragiline in Moderate Alzheimer’s Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD). Nave S, Doody RS, Boada M, Grimmer T, Savola JM, Delmar P, Pauly-Evers M, Nikolcheva T, Czech C, Borroni E, Ricci B, Dukart J, Mannino M, Carey T, Moran E, Gilaberte I, Muelhardt NM, Gerlach I, Santarelli L, Ostrowitzki S, Fontoura P. J Alzheimers Dis. 2017 May 26.. [Epub ahead of print]

F.I.: 3.92 doi: 10.3233/JAD-161309

 

Social Representation of Dementia: An Analysis of 5,792 Consecutive Cases Evaluated in a Memory Clinic. Cañabate P, Martínez G, Rosende-Roca M, Moreno M, Preckler S, Valero S, Sotolongo O, Hernández I, Alegret M, Ortega G, Espinosa A, Mauleón A, Vargas L, Rodríguez O, Abdelnour C, Sánchez D, Martín E, Ruiz A, Tárraga L, Boada M. J Alzheimers Dis. 2017 May 17. [Epub ahead of print]

F.I.: 3.92

 

The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer’s disease: An EADC study. Bosco P, Redolfi A, Bocchetta M, Ferrari C, Mega A, Galluzzi S, Austin M, Chincarini A, Collins DL, Duchesne S, Maréchal B, Roche A, Sensi F, Wolz R, Alegret M, Assal F, Balasa M, Bastin C, Bougea A, Emek-Savaş DD, Engelborghs S, Grimmer T, Grosu G, Kramberger MG, Lawlor B, Mandic Stojmenovic G, Marinescu M, Mecocci P, Molinuevo JL, Morais R, Niemantsverdriet E, Nobili F, Ntovas K, O’Dwyer S, Paraskevas GP, Pelini L, Picco A, Salmon E, Santana I, Sotolongo-Grau O, Spiru L, Stefanova E, Popovic KS, Tsolaki M, Yener GG, Zekry D, Frisoni GB. Alzheimers Dement. 2017 Mar 3. [Epub ahead of print]

F.I.: 11,619 pii: S1552-5260(17)30045-6. doi: 10.1016/j.jalz.2017.01.019.

 

Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype. Espinosa A, Alegret M, Pesini P, Valero S, Lafuente A, Buendía M, San José I, Ibarria M, Tejero MA, Giménez J, Ruiz S, Hernández I, Pujadas F, Martínez-Lage P, Munuera J, Arbizu J, Tárraga L, Hendrix SB, Ruiz A, Becker JT, Landau SM, Sotolongo-Grau O, Sarasa M, Boada M. J Alzheimers Dis. 2017;57(2):447-459.

F.I.: 13,314

 

FACEHBI: A Prospective Study of Risk Factors, Biomarkers and Cognition in a Cohort of Individuals with Subjective Cognitive Decline. Study Rationale and Research Protocols. Rodriguez-Gomez O, SanabriaA, Perez-Cordon A, Sanchez-Ruiz D, Abdelnour C, Valero S, Hernandez I, Rosende-Roca M, Mauleon A, Vargas L, Alegret M, Espinosa A, Ortega G, Guitart M, Gailhajanet A, Sotolongo-Grau O, Moreno-Grau S, Ruiz S, Tarragona M, Serra J, Martin E, Peleja E, Lomeña F, Campos F, Vivas A, Gomez-Chiari M, Tejero MA, Giménez J, Pesini P, Sarasa M, Martinez G, Ruiz A, Tarraga L, Boada M.

J Prev Alz Dis 2017;4(2):100-108 F.I.: n/a

 

Impact of Recruitment Methods in Subjective Cognitive Decline. Abdelnour C, Rodríguez-Gómez O, Alegret M, Valero S, Moreno-Grau S, Sanabria Á, Hernández I, Rosende-Roca M, Vargas L, Mauleón A, Sánchez D, Espinosa A, Ortega G, Pérez-Cordón A, Diego S, Gailhajanet A, Guitart M, Sotolongo-Grau Ó, Ruiz A, Tárraga L, Boada M. J Alzheimers Dis. 2017;57(2):625-632

F.I.: 3.92 doi: 10.3233/JAD-160915.


 

2016

 

Impact Factor: 79.26                                                                      Total pub.:  13

Printed: 79.26

 

Shared genetic contribution to ischemic stroke and Alzheimer’s disease. Matthew Traylor, Poneh Adib‐Samii, Denise Harold, the Alzheimer’s Disease Neuroimaging Initiative, The International Stroke Genetics Consortium (ISGC), UK Young Lacunar Stroke DNA resource, Martin Dichgans, Julie Williams, Cathryn M. Lewis, Hugh S. Markus, and and the METASTROKE and International Genomics of Alzheimer’s Project (IGAP) investigators. Ann Neurol. 2016 May; 79(5): 739–747.

 

Myriam Fornage, Elizabeth G Holliday, Pankaj Sharma, Joshua C Bis, Bruce M Psaty, Sudha Seshadri, Mike A Nalls, William J Devan, Giorgio Boncoraglio, Rainer Malik, Braxton D Mitchell, Steven J Kittner, M Arfan Ikram, Robert Clarke, Jonathan Rosand, James F Meschia, Cathie Sudlow, Peter M Rothwell, Christopher Levi, Steve Bevan, Laura L Kilarski, Matthew Walters, Vincent Thijs, Agnieszka Slowik, Arne Lindgren, Paul I W de Bakker, Jean‐Charles Lambert, Carla A Ibrahim‐Verbaas, Denise Harold, Adam C Naj, Rebecca Sims, Céline Bellenguez, Gyungah Jun, Anita L DeStefano, Joshua C Bis, Gary W Beecham, Benjamin Grenier‐Boley, Giancarlo Russo, Tricia A Thornton‐Wells, Nicola Jones, Albert V Smith, Vincent Chouraki, Charlene Thomas, M Arfan Ikram, Diana Zelenika, Badri N Vardarajan, Yoichiro Kamatani, Chiao‐Feng Lin, Amy Gerrish, Helena Schmidt, Brian Kunkle, Melanie L Dunstan, Agustin Ruiz, Marie‐Thçrèse Bihoreau, Seung‐Hoan Choi, Christiane Reitz, Florence Pasquier, Paul Hollingworth, Alfredo Ramirez, Olivier Hanon, Annette L Fitzpatrick, Joseph D Buxbaum, Dominique Campion, Paul K Crane, Clinton Baldwin, Tim Becker, Vilmundur Gudnason, Carlos Cruchaga, David Craig, Najaf Amin, Claudine Berr, Oscar L Lopez, Philip L De Jager, Vincent Deramecourt, Janet A Johnston, Denis Evans, Simon Lovestone, Luc Letenneur, Francisco J Morón, David C Rubinsztein, Gudny Eiriksdottir, Kristel Sleegers, Alison M Goate, Nathalie Fiçvet, Matthew J Huentelman, Michael Gill, Kristelle Brown, M Ilyas Kamboh, Lina Keller, Pascale Barberger‐Gateau, Bernadette McGuinness, Eric B Larson, Robert Green, Amanda J Myers, Carole Dufouil, Stephen Todd, David Wallon, Seth Love, Ekaterina Rogaeva, John Gallacher, Peter St George‐Hyslop, Jordi Clarimon, Alberto Lleo, Anthony Bayer, Debby W Tsuang, Lei Yu, Magda Tsolaki, Paola Bossù, Gianfranco Spalletta, Petroula Proitsi, John Collinge, Sandro Sorbi, Florentino Sanchez‐Garcia, Nick C Fox, John Hardy, Maria Candida Deniz Naranjo, Paolo Bosco, Robert Clarke, Carol Brayne, Daniela Galimberti, Michelangelo Mancuso, Fiona Matthews, European Alzheimer’s Disease Initiative (EADI), Genetic and Environmental Risk in Alzheimer’s Disease (GERAD), Alzheimer’s Disease Genetic Consortium (ADGC), Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE), Susanne Moebus, Patrizia Mecocci, Maria Del Zompo, Wolfgang Maier, Harald Hampel, Alberto Pilotto, Maria Bullido, Francesco Panza, Paolo Caffarra, Benedetta Nacmias, John R Gilbert, Manuel Mayhaus, Lars Lannfelt, Hakon Hakonarson, Sabrina Pichler, Minerva M Carrasquillo, Martin Ingelsson, Duane Beekly, Victoria Alvarez, Fanggeng Zou, Otto Valladares, Steven G Younkin, Eliecer Coto, Kara L Hamilton‐Nelson, Wei Gu, Cristina Razquin, Pau Pastor, Ignacio Mateo, Michael J Owen, Kelley M Faber, Palmi V Jonsson, Onofre Combarros, Michael C O’Donovan, Laura B Cantwell, Hilkka Soininen, Deborah Blacker, Simon Mead, Thomas H Mosley, Jr, David A Bennett, Tamara B Harris, Laura Fratiglioni, Clive Holmes, Renee F A G de Bruijn, Peter Passmore, Thomas J Montine, Karolien Bettens, Jerome I Rotter, Alexis Brice, Kevin Morgan, Tatiana M Foroud, Walter A Kukull, Didier Hannequin, John F Powell, Michael A Nalls, Karen Ritchie, Kathryn L Lunetta, John S K Kauwe, Eric Boerwinkle, Matthias Riemenschneider, Mercè Boada, Mikko Hiltunen, Eden R Martin, Reinhold Schmidt, Dan Rujescu, Li‐San Wang, Jean‐François Dartigues, Richard Mayeux, Christophe Tzourio, Albert Hofman, Markus M Nöthen, Caroline Graff, Bruce M Psaty, Lesley Jones, Jonathan L Haines, Peter A Holmans, Mark Lathrop, Margaret A Pericak‐Vance, Lenore J Launer, Lindsay A Farrer, Cornelia M van Duijn, Christine Van Broeckhoven, Valentina Moskvina, Sudha Seshadri, Julie Williams, Gerard D Schellenberg, and Philippe Amouyel

I.F.: 9.977 Published online 2016 Mar 30. doi:  10.1002/ana.24621

 

TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis. van der Zee J, Gijselinck I, Van Mossevelde S, Perrone F, Dillen L, Heeman B, Bäumer V, Engelborghs S, De Bleecker J, Baets J, Gelpi E, Rojas-García R, Clarimón J, Lleó A, Diehl-Schmid J, Alexopoulos P, Perneczky R, Synofzik M, Just J, Schöls L, Graff C, Thonberg H, Borroni B, Padovani A, Jordanova A, Sarafov S, Tournev I, de Mendonça A, Miltenberger-Miltényi G, Simões do Couto F, Ramirez A, Jessen F, Heneka MT, Gómez-Tortosa E, Danek A, Cras P, Vandenberghe R, De Jonghe P, De Deyn PP, Sleegers K, Cruts M, Van Broeckhoven C, Goeman J, Nuytten D, Smets K, Robberecht W, Damme PV, Bleecker J, Santens P, Dermaut B, Versijpt J, Michotte A, Ivanoiu A, Deryck O, Bergmans B, Delbeck J, Bruyland M, Willems C, Salmon E, Pastor P, Ortega-Cubero S, Benussi L, Ghidoni R, Binetti G, Hernández I, Boada M, Ruiz A, Sorbi S, Nacmias B, Bagnoli S, Sorbi S, Sanchez-Valle R, Llado A, Santana I, Rosário Almeida M, Frisoni GB, Maetzler W, Matej R, Fraidakis MJ, Kovacs GG, Fabrizi GM, Testi S. Hum Mutat. 2017 Mar;38(3):297-309

I.F.: 5.089 doi: 10.1002/humu.23161. Epub 2017 Jan 19.

 

Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-β Concentrations and Cognition Outcomes in Alzheimer’s Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial. Boada M, Anaya F, Ortiz P, Olazarán J, Shua-Haim JR, Obisesan TO, Hernández I, Muñoz J, Buendia M, Alegret M, Lafuente A, Tárraga L, Núñez L, Torres M, Grifols JR, Ferrer I, Lopez OL, Páez A.

J Alzheimers Dis. J Alzheimers Dis. 2017;56(1):129-143.

F.I.: 4,15 doi: 10.3233/JAD-160565. e-pub 2016 Nov 28.

 

Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer’s and Parkinson’s diseases. Ferrari R, Wang Y, Vandrovcova J, Guelfi S, Witeolar A, Karch CM, Schork AJ, Fan CC, Brewer JB; International FTD-Genomics Consortium (IFGC), International Parkinson’s Disease Genomics Consortium (IPDGC), International Genomics of Alzheimer’s Project (IGAP), Momeni P, Schellenberg GD, Dillon WP, Sugrue LP, Hess CP, Yokoyama JS, Bonham LW, Rabinovici GD, Miller BL, Andreassen OA, Dale AM, Hardy J, Desikan RS.

J Neurol Neurosurg Psychiatry. 2017 Feb;88(2):152-164.

F.I.: 6.81 doi: 10.1136/jnnp-2016-314411. Epub 2016 Nov 29.

 

Ferrari R, Hernandez DG, Nalls MA, Rohrer JD, Ramasamy A, Kwok JBJ, Dobson-Stone C, Schofield PR, Halliday GM, Hodges JR, Piguet O, Bartley L, Thompson E, Haan E, Hernández I, Ruiz A, Boada M, Borroni B, Padovani A, Cruchaga C, Cairns NJ, Benussi L, Binetti G, Ghidoni R, Forloni G, Albani D, Galimberti D, Fenoglio C, Serpente M, Scarpini E, Clarimón J, Lleó A, Blesa R, Landqvist Waldö M, Nilsson C, Mackenzie IRA, Hsiung GYR, Mann DMA, Grafman J, Morris CM, Attems J, Griffiths TD, McKeith IG, Thomas AJ, Pietrini P, Huey ED, Wassermann EM, Baborie A, Jaros E, Tierney MC, Pastor P, Razquin C, Ortega-Cubero S, Alonso E, Perneczky R, Diehl-Schmid J, Alexopoulos P, Kurz A, Rainero I, Rubino E, Pinessi L, Rogaeva E, St George-Hyslop P, Rossi G, Tagliavini F, Giaccone G, Rowe JB, Schlachetzki JCM, Uphill J, Collinge J, Mead S, Danek A, Van Deerlin VM, Grossman M, Trojanowski JQ, van der Zee J, Cruts M, Van Broeckhoven C, Cappa SF, Leber I, Hannequin D, Golfier V, Vercelletto M, Brice A, Nacmias B, Sorbi S, Bagnoli S, Piaceri I, Nielsen JE, Hjermind LE, Riemenschneider M, Mayhaus M, Ibach B, Gasparoni G, Pichler S, Gu W, Rossor MN, Fox NC, Warren JD, Spillantini MG, Morris HR, Rizzu P, Heutink P, Snowden JS, Rollinson S, Richardson A, Gerhard A, Bruni AC, Maletta R, Frangipane F, Cupidi C, Bernardi L, Anfossi M, Gallo M, Conidi ME, Smirne N, Rademakers R, Baker M, Dickson DW, Graff-Radford NR, Petersen RC, Knopman D, Josephs KA, Boeve BF, Parisi JE, Seeley WW, Miller BL, Karydas AM, Rosen H, van Swieten JC, Dopper EG, Seelaar H, Pijnenburg YAL, Scheltens P, Logroscino G, Capozzo R, Novelli V, Puca AA, Franceschi M, Postiglione A, Milan G, Sorrentino P, Kristiansen M, Chiang HH, Graff C, Pasquier F, Rollin A, Deramecourt V, Lebouvier T, Kapogiannis D, Ferrucci L, Pickering-Brown S, Singleton AB, Hardy J, Momeni P.

 

Genome-wide significant risk factors for Alzheimer’s disease: role in progression to dementia due to Alzheimer’s disease among subjects with mild cognitive impairment. Lacour A, Espinosa A, Louwersheimer E, Heilmann S, Hernández I, Wolfsgruber S, Fernández V, Wagner H, Rosende-Roca M, Mauleón A, Moreno-Grau S, Vargas L, Pijnenburg YA, Koene T, Rodríguez-Gómez O, Ortega G, Ruiz S, Holstege H, Sotolongo-Grau O, Kornhuber J, Peters O, Frölich L, Hüll M, Rüther E, Wiltfang J, Scherer M, Riedel-Heller S, Alegret M, Nöthen MM, Scheltens P, Wagner M, Tárraga L, Jessen F, Boada M, Maier W, van der Flier WM, Becker T, Ramirez A, Ruiz A. Mol Psychiatry. 2017 Jan;22(1):153-160. doi: 10.1038/mp.2016.18.

I.F.: 14,5 doi: 10.1038/mp.2016.18. Epub 2016 Mar 15.

 

Regiestries and cohorts to accelerate early phaseAlsheimer’s trials. A report from the E.U./U.S. clinical trials in Alzheimer’s Disease task force. Aise P, Touchon J, Andrieu S, Boada M, Doody R, Nosheny RL, Langbaum JB, Schneider L, Hendrix S, Wilcock G, Molinuevo JL, Ritchie C, Ousset P-J, Cummings J, Sperling R, DeKsky ST, Lovestone S, Hampel H, Petersen R, Legrand V, Egan M, Randolph C, Salloway S, Weiner M, Vellas B and Task Force members.

F.I.: n/a

 

FACEHBI: A Prospective Study Of Risk Factors, Biomarkers and Cognition in a Cohort of Individuals with Subjective Cognitive Decline. Study Rationale and Research Protocols

Rodriguez-Gomez, A. Sanabria, A. Perez-Cordon, D. Sanchez-Ruiz, C. Abdelnour, S. Valero, I. Hernandez, M. Rosende-Roca, A. Mauleon, L. Vargas, M. Alegret, A. Espinosa, G. Ortega, M. Guitart, A. Gailhajanet, O. Sotolongo-Grau, S. Moreno-Grau, S. Ruiz, M. Tarragona, J. Serra, E. Martin, E. Peleja, F. Lomeña, F. Campos, A. Vivas, M.Gomez-Chiari, M.A. Tejero, J. Giménez, P. Pesini, M. Sarasa, G.Martinez, A. Ruiz, L. Tarraga, M.Boada

The Journal of Prevention of Alzheimer’s Disease (JPAD). http://dx.doi.org/10.14283/jpad.2016.122

F.I:  n/a

 

Whole exome sequencing analysis reveals TRPV3 as a risk factor for cardioembolic stroke. Carrera C, Jiménez-Conde J, Derdak S, Rabionet K, Vives-Bauzá C, Soriano-Tárrega C, Giralt-Steinhauer E, Mola M, Diaz-Navarro RM, Tur S, Muiño E, Gallego-Fabrega C, Beltran S, Roquer J, Ruiz A, Sotolongo-Grau O, Krupinski J, Lee JM, Cruchaga C, Delgado P, Malik R, Worrall BB, Seshadri S, Montaner J, Fernández-Cadenas I1; Metastroke Consortium, ISGC Consortium and Genestroke Consortium. Thromb Haemost. 2016 Nov 30;116(6):1165-1171.

I.F.: 5.255 Epub 2016 Sep 8.

 

Alzheimer’s disease risk variants modulate endophenotypes in mild cognitive impairment. Louwersheimer E, Wolfsgruber S, Espinosa A, Lacour A, Heilmann-Heimbach S, Alegret M, Hernández I, Rosende-Roca M, Tárraga L, Boada M, Kornhuber J, Peters O, Frölich L, Hüll M, Rüther E1, Wiltfang J, Scherer M, Riedel-Heller S, Jessen F, Nöthen MM, Maier W, Koene T, Scheltens P, Holstege H, Wagner M, Ruiz A, van der Flier WM, Becker T, Ramirez A. Alzheimers Dement. 2016 Aug;12(8):872-81. doi: 10.1016/j.jalz.2016.01.006

I.F. 12,41 Epub 2016 Feb 26

 

Alzheimer’s disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia. Abdelnour C, van Steenoven I, Londos E, Blanc F, Auestad B, Kramberger MG, Zetterberg H, Mollenhauer B, Boada M, Aarsland D; European DLB Consortium. Mov Disord. 2016 Aug;31(8):1203-8.

I.F.: 6.01 doi: 10.1002/mds.26668. Epub 2016 Jun 14

 

Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials. Vandenberghe R, Rinne JO, Boada M, Katayama S, Scheltens P, Vellas B, Tuchman M, Gass A, Fiebach JB, Hill D, Lobello K, Li D, McRae T, Lucas P, Evans I, Booth K, Luscan G, Wyman BT, Hua L, Yang L, Brashear HR, Black RS; Bapineuzumab 3000 and 3001 Clinical Study Investigators. Alzheimers Res Ther. 2016 May 12;8(1):18.

I.F.: 5.2 doi: 10.1186/s13195-016-0189-7.

 

Genome research in pre-dementia stages of Alzheimer’s disease. Moreno-Grau S1, Ruiz A1. Expert Rev Mol Med. 2016 May 30;18:e11.

F.I.: 5.71 doi: 10.1017/erm.2016.12.

 

Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer’s Disease. Ibarria M, Alegret M, Valero S, Morera A, Guitart M, Cañabate P, Moreno M, Lara S, Diego S, Hernández J, Tantinyá N, Vera M, Hernández I, Becker JT, Ruíz A, Boada M, Tárraga L. J Alzheimers Dis. 2015;50(2):559-66.

I.F.: 4.15 doi: 10.3233/JAD-150455. PMID: 26757182


 

 

2015

 

Impact Factor: 135.03                                                                   Total pub.:  19

 

A Longitudinal Study of Transitions Between Informal and Formal Care in Alzheimer Disease Using Multistate Models in the European ICTUS Cohort. Coley N1, Gallini A2, Garès V3, Gardette V2, Andrieu S2; ICTUS/DSA group.

Collaborators (42): Vellas B, Reynish E, Ousset PJ, Andrieu S, Burns A, Pasquier F, Frisoni G, Salmon E, Michel JP, Zekry DS, Boada M, Dartigues JF, Olde-Rikkert MG, Rigaud AS, Winblad B, Malick A, Sinclair A, Frölich L, Scheltens P, Ribera C, Touchon J, Robert P, Salva A, Waldmar G, Bullock R, Costa-Tsolaki M, Rodriguez G, Spiru L, Jones RW, Stiens G, Stoppe G, Eriksdotter Jönhagen M, Cherubini A, Lage PM, Gomez-Isla T, Camus V, Agüera-Morales E, Lopez F, Andrieu S, Savy S, Cantet C, Coley N. J Am Med Dir Assoc. 2015 Dec;16(12):1104.e1-7

I.F.: 4,94 doi: 10.1016/j.jamda.2015.09.010.

 

Clinicopathological Correlations and Concomitant Pathologies in Rapidly Progressive Dementia: A Brain Bank Series. Grau-Rivera O, Gelpi E, Nos C, Gaig C, Ferrer I, Saiz A, Lladó A, Molinuevo JL, Graus F, Sánchez-Valle R; Neurological Tissue Bank Collaborative Group. Neurodegener Dis. 2015;15(6):350-60.

I.F.: 3.51 doi: 10.1159/000439251. Epub 2015 Oct 31.

 

Common polygenic variation enhances risk prediction for Alzheimer’s disease. Escott-Price V, Sims R, Bannister C, Harold D, Vronskaya M, Majounie E, Badarinarayan N; GERAD/PERADES; IGAPconsortia, Morgan K, Passmore P, Holmes C, Powell J, Brayne C, Gill M, Mead S, Goate A, Cruchaga C, Lambert JC, van Duijn C, Maier W, Ramirez A, Holmans P, Jones L, Hardy J, Seshadri S, Schellenberg GD, Amouyel P, Williams J. Brain. 2015 Dec;138(Pt 12):3673-84.

I.F.: 9.2

 

Assessing the Role of TUBA4A Gene in Frontotemporal Degeneration. Dols-Icardo O, Iborra O, Valdivia J, Pastor P, Ruiz A, López de Munain A, Sánchez-Valle R, Álvarez V, Sánchez-Juan P, Lleó A, Fortea J, Blesa R, Cardona F, Baquero M, Alonso MD, Ortega-Cubero S, Pastor MA, Razquin C, Boada M, Hernández I, Gorostidi A, Moreno F, Zulaica M, Lladó A, Coto E, Combarros O, Pérez-Tur J, Clarimón J on behalf of The Dementia Genetics Spanish Consortium (DEGESCO). Neurobiol.Aging. Neurobiol Aging. 2016 Feb;38:215.e13-4.

I.F.: 5,01 doi: 10.1016/j.neurobiolaging.2015.10.030. Epub 2015 Nov 5.

 

MAPT H1 Haplotype is Associated with Late-Onset Alzheimer’s Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium. Pastor P, Moreno F, Clarimón J, Ruiz A, Combarros O, Calero M, López de Munain A, Bullido MJ, de Pancorbo MM, Carro E, Antonell A, Coto E, Ortega-Cubero S, Hernandez I, Tárraga L, Boada M, Lleó A, Dols-Icardo O, Kulisevsky J, Vázquez-Higuera JL, Infante J, Rábano A, Fernández-Blázquez MÁ, Valentí M, Indakoetxea B, Barandiarán M, Gorostidi A, Frank-García A, Sastre I, Lorenzo E, Pastor MA, Elcoroaristizabal X, Lennarz M, Maier W, Rámirez A, Serrano-Ríos M, Lee SE, Sánchez-Juan P. J Alzheimers Dis. 2015 Sep 29;49(2):343-52.

I.F.: 4.15 doi: 10.3233/JAD-150555.

 

A Truncating Mutation in Alzheimer’s Disease Inactivates Neuroligin-1 Synaptic Function. Tristán-Clavijo, E, Camacho-Garcia, R J, Robles-Lanuza, E, Ruiz, A, van der Zee, J, Van Broeckhoven, C, Hernández I, Martínez-Mir A, Scholl, F G (2015). Neurobiology of Aging. 2015 Dec;36(12):3171-5.

I.F.: 5,01 doi: 10.1016/j.neurobiolaging.2015.09.004. Epub 2015 Sep 10

 

A novel Alzheimer disease locus located near the gene encoding tau protein. Jun G, Ibrahim-Verbaas CA, Vronskaya M, Lambert JC, Chung J, Naj AC, Kunkle BW, Wang LS, Bis JC, Bellengez C, Harold D, Lunetta KL, Destefano AL, Grenier-Boley B, Sims R, Beecham GW, Smith AV, Chouraki V, Hamilton-Nelson KL7, Ikram MA, Fievet N, Denning N, Martin ER, Schmidt H, Kamatani Y, Dunstan ML, Valladares O, Laza AR, Zelenika D, Ramirez A, Foroud TM, Choi SH, Boland A, Becker T, Kukull WA, van der Lee SJ, Pasquier F, Cruchaga C, Beekly D, Fitzpatrick AL, Hanon O, Gill M, Barber R, Gudnason V, Campion D, Love S, Bennett DA, Amin N, Berr C, Tsolaki M, Buxbaum JD, Lopez OL, Deramecourt V, Fox NC, Cantwell LB, Tárraga L, Dufouil C, Hardy J, Crane PK, Eiriksdottir G, Hannequin D, Clarke R, Evans D, Mosley TH Jr, Letenneur L, Brayne C, Maier W, De Jager P, Emilsson V, Dartigues JF, Hampel H, Kamboh MI, de Bruijn RF, Tzourio C, Pastor P, Larson EB, Rotter JI, O’Donovan MC, Montine TJ, Nalls MA, Mead S, Reiman EM, Jonsson PV, Holmes C, St George-Hyslop PH, Boada M, Passmore P, Wendland JR, Schmidt R, Morgan K, Winslow AR, Powell JF, Carasquillo M, Younkin SG, Jakobsdóttir J, Kauwe JS, Wilhelmsen KC, Rujescu D, Nöthen MM, Hofman A, Jones L; IGAP Consortium, Haines JL, Psaty BM, Van Broeckhoven C, Holmans P, Launer LJ, Mayeux R, Lathrop M, Goate AM, Escott-Price V, Seshadri S, Pericak-Vance MA, Amouyel P, Williams J, van Duijn CM, Schellenberg GD, Farrer LA. Mol Psychiatry. 2016 Jan;21(1):108-117.

I.F.: 14.50 doi: 10.1038/mp.2015.23. Epub 2015 Mar 17.

 

Diagostic accuracy of FTD behavioural frontotemporal dementia criteria in a clinicopathological cohort. Balasa M, Gelpi E, Martín I, Antonell A, Rey M, Grau-Rivera O, Molinuevo J, Sánchez-Valle R, Lladó A; Catalan collaborative Study Group for FTLD. Neuropathol Appl Neurobiol. 2015 Dec;41(7):882-92.

doi: 10.1111/nan.12194. Epub 2015 May 2.

I.F.: 3.93 doi: 10.1111/nan.12194.

 

Concordance between Subjective and Objective Memory Impairment in Volunteer Subjects. Alegret M, Rodríguez O, Espinosa A, Ortega G, Sanabria A, Valero S, Hernández I, Rosende-Roca M, Vargas L, Abdelnour C, Mauleón A, Gailhajanet A, Martín E, Tárraga L, Rentz DM, Amariglio RE, Ruíz A, Boada M. J Alzheimers Dis. 2015 Oct 27;48(4):1109-17.

I.F.: 4,15 doi: 10.3233/JAD-150594.

 

Analysis of the CHCHD10 gene in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Spain. Dols-Icardo, O , Nebot I , Gorostidi A, Ortega-Cubero S , Hernández I, Rojas-García R, García-Redondo A, Povedano M, Lladó A, Álvarez V, Sánchez-Juan P, Pardo J , Jericó I, Vázquez-Costa J, Sevilla T, Cardona F, Indakoechea B, Moreno F, Fernández-Torrón R, Muñoz-Llahuna L, Moreno-Grau S, Rosende-Roca M, Vela A, Muñoz-Blanco JL, Combarros O, Coto E, Alcolea D, Fortea J, Lleó A, Sánchez-Valle R, Esteban-Pérez J, Ruiz A, Pastor P, López De Munain A, Pérez-Tur J, Clarimón J. Brain. 2015 Dec;138(Pt 12):e400.

I.F.: 9.19 doi:10.1093/brain/awv175.

 

 

Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies. Rabin LA, Smart CM, Crane PK, Amariglio RE, Berman LM, Boada M, Buckley RF, Chételat G, Dubois B, Ellis KA, Gifford KA, Jefferson AL, Jessen F, Katz MJ, Lipton RB, Luck T, Maruff P, Mielke MM, Molinuevo JL, Naeem F, Perrotin A, Petersen RC, Rami L, Reisberg B, Rentz D, Riedel-Heller SG, Risacher SL, Rodriguez O, Sachdev PS, Saykin AJ, Slavin MJ, Snitz BE, Sperling RA, Tandetnik C, van der Flier WM, Wagner M, Wolfsgruber S, Sikkes SA. J Alzheimers Dis. 2015 Sep 24;48 Suppl 1:S63-86..

I.F.: 4.15 doi: 10.3233/JAD-150154

 

Validation of the Spanish Version of the Face Name Associative Memory Exam (S-FNAME) in Cognitively Normal Older Individuals. Alegret M, Valero S, Ortega G, Espinosa A, Sanabria A, Hernández I, Rodríguez O, Rosende-Roca M, Mauleón A, Vargas L, Martín E, Ruíz A, Tárraga L, Amariglio RE, Rentz DM, Boada M. Arch Clin Neuropsychol. 2015 Nov;30(7):712-20.

I.F.: 1.99 Epub 2015 Aug 18. doi: 10.1093/arclin/acv050.

 

Influence of Sampling and Recruitment Methods in Studies of Subjective Cognitive Decline. Rodríguez-Gómez O, Abdelnour C, Jessen F, Valero 3, Boada M. J Alzheimers Dis. 2015 Sep 24;48 Suppl 1:S99-S107.

I.F.: 4.15 doi: 10.3233/JAD-150189

 

Evaluation of Candidate Genes Related to Neuronal Apoptosis in Late-Onset Alzheimer’s Disease. Moreno-Grau S, Barneda B, Carriba P, Marín J, Sotolongo-Grau O, Hernández I, Rosende-Roca M, Mauleón A, Vargas L, Espinosa A, Alegret M, Rodriguez O, Ortega G, Fernández MV, López-Arrieta J, Tárraga L, Boada M, Antúnez C, López J, Ruiz A, Comella JX J Alzheimers Dis. 2015;45(2):621-9.

I.F.: 4.15 doi: 10.3233/JAD-142721

 

Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease. Desikan RS, Schork AJ, Wang Y, Thompson WK, Dehghan A, Ridker PM, Chasman DI, McEvoy LK, Holland D, Chen CH, Karow DS, Brewer JB, Hess CP, Williams J, Sims R, O’Donovan MC, Choi SH, Bis JC, Ikram MA, Gudnason V, DeStefano AL, van der Lee SJ, Psaty BM, van Duijn CM, Launer L, Seshadri S, Pericak-Vance MA, Mayeux R, Haines JL, Farrer LA, Hardy J, Ulstein ID, Aarsland D, Fladby T, White LR, Sando SB, Rongve A, Witoelar A, Djurovic S, Hyman BT, Snaedal J, Steinberg S, Stefansson H, Stefansson K, Schellenberg GD, Andreassen OA, Dale AM; Inflammation Working Group and International Genomics of Alzheimer’s Disease Project (IGAP) and DemGene Investigators. Circulation. 2015 Jun 9;131(23):2061-9.

I.F.: 3.94

 

Genetic variability in SQSTM1 and risk of early-onset Alzheimer dementia: a European early-onset dementia consortium study. Cuyvers E, van der Zee J, Bettens K, Engelborghs S, Vandenbulcke M, Robberecht C, Dillen L, Merlin C, Geerts N, Graff C, Thonberg H, Chiang HH, Pastor P, Ortega-Cubero S, Pastor MA, Diehl-Schmid J, Alexopoulos P, Benussi L, Ghidoni R, Binetti G, Nacmias B, Sorbi S, Sanchez-Valle R, Lladó A, Gelpi E, Almeida MR, Santana I, Clarimon J, Lleó A, Fortea J, de Mendonça A, Martins M, Borroni B, Padovani A, Matěj R, Rohan Z, Ruiz A, Frisoni GB, Fabrizi GM, Vandenberghe R, De Deyn PP, Van Broeckhoven C, Sleegers K; BELNEU Consortium and of the EU EOD Consortium. Neurobiol Aging. 2015 May;36(5):2005.e15-22.

I.F.: 5.01 doi: 10.1016/j.neurobiolaging.2015.02.014. Epub 2015 Feb 19.

 

Differentiated clinical presentation of early and late-onset Alzheimer’s disease: is 65 years of age providing a reliable threshold? Palasí A, Gutiérrez-Iglesias B, Alegret M, Pujadas F, Olabarrieta M, Liébana D, Quintana M, Álvarez-Sabín J, Boada M. J Neurol. 2015 May;262(5):1238-46

I.F.: 3,37 (2013) doi: 10.1007/s00415-015-7698-3. Epub 2015 Mar 21

 

PLD3 in non-familial Alzheimer’s disease. Heilmann S, Drichel D, Clarimon J, Fernández V, Lacour A, Wagner H, Thelen M, Hernández I, Fortea J, Alegret M, Blesa R, Mauleón A, Roca MR, Kornhuber J, Peters O, Heun R, Frölich L, Hüll M, Heneka MT, Rüther E, Riedel-Heller S, Scherer M, Wiltfang J, Jessen F, Becker T, Tárraga L, Boada M, Maier W, Lleó A, Ruiz A, Nöthen MM, Ramirez A. Nature. 2015 Apr 2;520(7545):E3-5.

F.I.: 41.45 doi: 10.1038/nature14039.

 

Retirement age and the age of onset of Alzheimer’s disease: results from the ICTUS study. Grotz C, Letenneur L, Bonsang E, Amieva H, Meillon C, Quertemont E, Salmon E, Adam S; ICTUS/DSA group. PLoS One. 2015 Feb 25;10(2)

F.I. 3.23 (extret de Research Gate) e0115056. doi: 10.1371


 

2014

 

Impact Factor: 127,5                                                                    Total pub.: 25

Printed: 100,112

E-pub: 27,406

 

Treatment of Alzheimer disease using combination therapy with plasma exchange and haemapheresis with albumin and intravenous immunoglobulin: Rationale and treatment approach of the AMBAR (Alzheimer Management By Albumin Replacement) study. Boada M, Ramos-Fernández E, Guivernau B, Muñoz FJ, Costa M, Ortiz AM, Jorquera JI, Núñez L, Torres M, Páez A. Neurologia. 2016 Sep;31(7):473-81 9.

PDF

I.F.: 1,35 doi: 10.1016/j.nrl.2014.02.003. Epub 2014 Jul

 

Convergent genetic and expression data implicate immunity in Alzheimer’s disease. International Genomics of Alzheimer’s Disease Consortium IGAP. Alzheimers Dement. 2015 Jun;11(6):658-71.

I.F.: 17.47 doi: 10.1016/j.jalz.2014.05.1757. Epub 2014 Dec 20

 

(Tret de la propia web Des 2014)

Jones L, Lambert J, Wang L, Choi S, Harold D, Vedernikov A, Escott-Price V, Stone T, Richards A, Bellenguez C, Ibrahim-Verbaas CA, Naj AC, Sims R, Gerrish A, Jun G, DeStefano AL, Bis JC, Beecham GW, Grenier-Boley B, Russo G, Thornton-Wells TA, Jones N, Smith AV, Chouraki V, Thomas C, Ikram MA, Zelenika D, Vardarajan BN, Kamatani Y, Lin C, Schmidt H, Kunkle BW, Dunstan ML, Ruiz A, Bihoreau M, Reitz C, Pasquier F, Hollingworth P, Hanon O, Fitzpatrick AL, Buxbaum JD, Campion D, Crane PK, Becker T, Gudnason V, Cruchaga C, Craig D, Amin N, Berr C, Lopez OL, De Jager PL, Deramecourt V, Johnston JA, Evans D, Lovestone S, Letteneur L, Kornhuber J, Tárraga L, Rubinsztein DC, Eiriksdottir G, Sleegers K, Goate AM, Fiévet N, Huentelman MJ, Gill M, Emilsson V, Brown K, Kamboh MI, Keller L, Barberger-Gateau P, McGuinness B, Larson EB, Myers AJ, Dufouil C, Todd S, Wallon D, Love S, Kehoe P, Rogaeva E, Gallacher J, St George-Hyslop P, Clarimon J, Lleò A, Bayer A, Tsuang DW, Yu L, Tsolaki M, Bossù P, Spalletta G, Proitsi P, Collinge J, Sorbi S, Garcia FS, Fox N, Hardy J, Deniz Naranjo MC, Razquin C, Bosco P, Clarke R, Brayne C, Galimberti D, Mancuso M, Mrc Cfas, Moebus S, Mecocci P, Zompo MD, Maier W, Hampel H, Pilotto A, Bullido M, Panza F, Caffarra P, Nacmias B, Gilbert JR, Mayhaus M, Jessen F, Dichgans M, Lannfelt L, Hakonarson H, Pichler S, Carrasquillo MM, Ingelsson M, Beekly D, Alavarez V, Zou F, Valladares O, Younkin SG, Coto E, Hamilton-Nelson KL, Mateo I, Owen MJ, Faber KM, Jonsson PV, Combarros O, O’Donovan MC, Cantwell LB, Soininen H, Blacker D, Mead S, Mosley TH Jr, Bennett DA, Harris TB, Fratiglioni L, Holmes C, de Bruijn RF, Passmore P, Montine TJ, Bettens K, Rotter JI, Brice A, Morgan K, Foroud TM, Kukull WA, Hannequin D, Powell JF, Nalls MA, Ritchie K, Lunetta KL, Kauwe JS, Boerwinkle E, Riemenschneider M, Boada M, Hiltunen M, Martin ER, Pastor P, Schmidt R, Rujescu D, Dartigues J, Mayeux R, Tzourio C, Hofman A, Nöthen MM, Graff C, Psaty BM, Haines JL, Lathrop M, Pericak-Vance MA, Launer LJ, Farrer LA, van Duijn CM, Van Broeckhoven C, Ramirez A, Schellenberg GD, Seshadri S, Amouyel P, Williams J, Holmans PA.

 

Association of TMEM106B rs1990622 Marker and Frontotemporal Dementia: Evidence for a Recessive Effect and Meta-Analysis. Hernández I, Rosende-Roca M, Alegret M, Mauleón A, Espinosa A, Vargas L, Sotolongo-Grau O, Tárraga L, Boada M, Ruiz A. J Alzheimers Dis. 2015;43(1):325-34.

doi: 10.3233/JAD-132432. E-pub 2014

I.F: 4.51

 

A Phase II Trial of Tideglusib in Alzheimer’s Disease. Lovestone S, Boada M, Dubois B, Hüll M, Rinne JO, Huppertz HJ, Calero M, Andrés MV, Gómez-Carrillo B, León T, Del Ser T. J Alzheimers Dis. 2015 Jan 1;45(1):75-88.

I.F.: 3,612

doi: 10.3233/JAD-141959

e-pub: 23 Dec 14

 

Association between cell-bound blood amyloid-β(1–40) levels and hippocampus volume. Sotolongo-Grau O, Pesini P, Valero S, Lafuente A, Buendia M, Pérez-Grijalba V, José IS, Ibarria M, Tejero MA, Giménez J, Hernández I, Tárraga L, Ruiz A, Boada M, Sarasa M. Alzheimers Res Ther. 2014 Oct 20;6(5-8):56. eCollection 2014.

PDF

I.F.: 3,500 DOI10.1186/s13195-014-0056-3

Open Access

 

Prevention of Alzheimer’s Disease: A Global Challenge for Next Generation Neuroscientists. Rodríguez-Gómez O, Palacio-Lacambra ME, Palasí A, Ruiz-Laza A, Boada-Rovira M. J Alzheimers Dis. 42 (2014) S515–S523.

I.F.: 3,612

DOI 10.3233/JAD-141479

On-line: 2014 Oct 28

 

Aβ1-17 is a Major Amyloid-β Fragment Isoform in Cerebrospinal Fluid and Blood with Possible Diagnostic Value in Alzheimer’s Disease. Pérez-Grijalba V, Pesini P, Allué JA, Sarasa L, Montañés M, Lacosta AM, Casabona D, San-José I, Boada M, Tárraga L, Ruiz A, Sarasa M. J Alzheimers Dis. 2015 Jan 1;43(1):47-56

I.F.:  3,612

On-line: Thursday, July 24, 2014

doi: 10.3233/JAD-140156

 

A colorectal cancer susceptibility new variant at 4q26 in the Spanish population identified by genome-wide association analysis. Real LM, Ruiz A, Gayán J, González-Pérez A, Sáez ME4, Ramírez-Lorca R, Morón FJ, Velasco J, Marginet-Flinch R, Musulén E, Carrasco JM, Moreno-Rey C, Vázquez E, Chaves-Conde M, Moreno-Nogueira JA, Hidalgo-Pascual M, Ferrero-Herrero E, Castellví-Bel S, Castells A, Fernandez-Rozadilla C, Ruiz-Ponte C, Carracedo A, González B, Alonso S, Perucho M. PLoS One. 2014 Jun 30;9(6):e101178.

PDF

I.F: 3,73

(IF 2012 que era el disponible a data de la publicació, IF 2013 diferent)

doi: 10.1371/journal.pone.0101178. eCollection 2014.

 

Investigation of the role of rare TREM2 variants in frontotemporal dementia subtypes. Thelen M, Razquin C, Hernández I, Gorostidi A, Sánchez-Valle R, Ortega-Cubero S, Wolfsgruber S, Drichel D, Fliessbach K, Duenkel T, Damian M, Heilmann S, Slotosch A, Lennarz M, Seijo-Martínez M, Rene R, Kornhuber J, Peters O, Luckhaus C, Jahn H, Hüll M, Rüther E, Wiltfang J, Lorenzo E, Gascon J, Lleó A, Lladó A, Campdelacreu J, Moreno F, Ahmadzadehfar H; Dementia Genetics Spanish Consortium (DEGESCO), Fortea J, Indakoetxea B, Heneka MT, Wetter A, Pastor MA, Riverol M, Becker T, Frölich L, Tárraga L, Boada M, Wagner M, Jessen F, Maier W, Clarimón J, López de Munain A, Ruiz A, Pastor P, Ramirez A. Neurobiol Aging. 2014 Nov;35(11):2657.e13-9.

I.F.:  4,853

doi: 10.1016/j.neurobiolaging.2014.06.018.

On-line: 2014 Jun 20.

 

Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration. Van der Zee J, Van Langenhove T, Kovacs GG, Dillen L, Deschamps W, Engelborghs S, Matěj R, Vandenbulcke M, Sieben A, Dermaut B, Smets K, Van Damme P, Merlin C, Laureys A, Van Den Broeck M, Mattheijssens M, Peeters K, Benussi L, Binetti G, Ghidoni R, Borroni B, Padovani A, Archetti S, Pastor P, Razquin C, Ortega-Cubero S, Hernández I, Boada M, Ruiz A, de Mendonça A, Miltenberger-Miltényi G, do Couto FS, Sorbi S, Nacmias B, Bagnoli S, Graff C, Chiang HH, Thonberg H, Perneczky R, Diehl-Schmid J, Alexopoulos P, Frisoni GB, Bonvicini C, Synofzik M, Maetzler W, Vom Hagen JM, Schöls L, Haack TB, Strom TM, Prokisch H, Dols-Icardo O, Clarimón J, Lleó A, Santana I, Almeida MR, Santiago B, Heneka MT, Jessen F, Ramirez A, Sanchez-Valle R, Llado A, Gelpi E, Sarafov S, Tournev I, Jordanova A, Parobkova E, Fabrizi GM, Testi S, Salmon E, Ströbel T, Santens P, Robberecht W, De Jonghe P, Martin JJ, Cras P, Vandenberghe R, De Deyn PP, Cruts M, Sleegers K, Van Broeckhoven C. Acta Neuropathol. 2014 Sep;128(3):397-410.

PDF

I.F.: 9,734

(FI 2012 de la pròpia web del 2014)

doi: 10.1007/s00401-014-1298-7.

On-line: 2014 Jun 5.

 

Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders. Gelpi E, Navarro-Otano J, Tolosa E, Gaig C, Compta Y, Rey MJ, Martí MJ, Hernández I, Valldeoriola F, Reñé R, Ribalta T. Mov Disord. 2014 Jul;29(8):1010-8. doi: 10.1002/mds.25776. Epub 2014 Jan 2.

I.F.: 5,634

doi: 10.1002/mds.25776.

On-Line: 14 Jan 02

 

Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer’s disease from mild cognitive impairment. Alegret M, Cuberas-Borrós G, Espinosa A, Valero S, Hernández I, Ruíz A, Becker JT, Rosende-Roca M, Mauleón A, Sotolongo O, Castell-Conesa J, Roca I, Tárraga L, Boada M. J Alzheimers Dis. 2014;41(3):739-48.

PDF

I.F.: 3,612

doi: 10.3233/JAD-132516.

 

Effects of Gingko biloba supplementation in Alzheimer’s disease patients receiving cholinesterase inhibitors: data from the ICTUS study. Canevelli M, Adali N, Kelaiditi E, Cantet C, Ousset PJ, Cesari M; ICTUS/DSA Group. Phytomedicine. 2014 May 15;21(6):888-92.

PDF

I.F.: 2,877

doi: 10.1016/j.phymed.2014.01.003.

On-line: 2014 Feb 16.

 

A 2-year prospective cohort study of antidementia drug non-persistency in mild-to-moderate Alzheimer’s disease in Europe : predictors of discontinuation and switch in the ICTUS study. Gardette V, Lapeyre-Mestre M, Piau A, Gallini A, Cantet C, Montastruc JL, Vellas B, Andrieu S; ICTUS Group. CNS Drugs. 2014 Feb;28(2):157-70.

I.F.: 4,376

doi: 10.1007/s40263-013-0133-3.

On-line: 14 Jan 10

 

Utilidad del subtest Semejanzas de la Escala de Inteligencia de Wechsler para Adultos-III y su relación con la conciencia de déficit en la evaluación forense del deterioro cognitivo. Espinosa A, Alegret A, Ibarria M, Ortega G, Cañabate P, Boada M. Revista Española de Medicina Legal. 10.1016/j.reml.2014.03.001

PDF

I.F.: 0,22

 

A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy. Tolosa E, Litvan I, Höglinger GU, Burn D, Lees A, Andrés MV, Gómez-Carrillo B, León T, Del Ser T; TAUROS Investigators. Mov Disord. 2014 Apr;29(4):470-8. doi: 10.1002/mds.25824..

I.F.: 5,634

On-line: 2014 Feb 14

Boada M, Lafuente A, Hernandez I consten com a “collaborators” al TAUROS Investigators

 

Frontotemporal dementia and its subtypes: a genome-wide association study. Ferrari R, Hernandez DG, Nalls MA, Rohrer JD, Ramasamy A, Kwok JB, Dobson-Stone C, Brooks WS, Schofield PR, Halliday GM, Hodges JR, Piguet O, Bartley L, Thompson E, Haan E, Hernández I, Ruiz A, Boada M, Borroni B, Padovani A, Cruchaga C, Cairns NJ, Benussi L, Binetti G, Ghidoni R, Forloni G, Galimberti D, Fenoglio C, Serpente M, Scarpini E, Clarimón J, Lleó A, Blesa R, Waldö ML, Nilsson K, Nilsson C, Mackenzie IR, Hsiung GY, Mann DM, Grafman J, Morris CM, Attems J, Griffiths TD, McKeith IG, Thomas AJ, Pietrini P, Huey ED, Wassermann EM, Baborie A, Jaros E, Tierney MC, Pastor P, Razquin C, Ortega-Cubero S, Alonso E, Perneczky R, Diehl-Schmid J, Alexopoulos P, Kurz A, Rainero I, Rubino E, Pinessi L, Rogaeva E, St George-Hyslop P, Rossi G, Tagliavini F, Giaccone G, Rowe JB, Schlachetzki JC, Uphill J, Collinge J, Mead S, Danek A, Van Deerlin VM, Grossman M, Trojanowski JQ, van der Zee J, Deschamps W, Van Langenhove T, Cruts M, Van Broeckhoven C, Cappa SF, Le Ber I, Hannequin D, Golfier V, Vercelletto M, Brice A, Nacmias B, Sorbi S, Bagnoli S, Piaceri I, Nielsen JE, Hjermind LE, Riemenschneider M, Mayhaus M, Ibach B, Gasparoni G, Pichler S, Gu W, Rossor MN, Fox NC, Warren JD, Spillantini MG, Morris HR, Rizzu P, Heutink P, Snowden JS, Rollinson S, Richardson A, Gerhard A, Bruni AC, Maletta R, Frangipane F, Cupidi C, Bernardi L, Anfossi M, Gallo M, Conidi ME, Smirne N, Rademakers R, Baker M, Dickson DW, Graff-Radford NR, Petersen RC, Knopman D, Josephs KA, Boeve BF, Parisi JE, Seeley WW, Miller BL, Karydas AM, Rosen H, van Swieten JC, Dopper EG, Seelaar H, Pijnenburg YA, Scheltens P, Logroscino G, Capozzo R, Novelli V, Puca AA, Franceschi M, Postiglione A, Milan G, Sorrentino P, Kristiansen M, Chiang HH, Graff C, Pasquier F, Rollin A, Deramecourt V, Lebert F, Kapogiannis D, Ferrucci L, Pickering-Brown S, Singleton AB, Hardy J, Momeni P. Lancet Neurol 2014; 13: 686–99

I.F.: 23,92

 

Gene-wide analysis detects two new susceptibility genes for Alzheimer’s disease. Escott-Price V, Bellenguez C, Wang LS, Choi SH, Harold D, Jones L, Holmans P, Gerrish A, Vedernikov A, Richards A, DeStefano AL, Lambert JC, Ibrahim-Verbaas CA, Naj AC, Sims R, Jun G, Bis JC, Beecham GW, Grenier-Boley B, Russo G1, Thornton-Wells TA, Denning N, Smith AV, Chouraki V, Thomas C, Ikram MA, Zelenika D, Vardarajan BN, Kamatani Y, Lin CF, Schmidt H, Kunkle B, Dunstan ML, Vronskaya M; United Kingdom Brain Expression Consortium, Johnson AD, Ruiz A, Bihoreau MT, Reitz C, Pasquier F, Hollingworth P, Hanon O, Fitzpatrick AL, Buxbaum JD, Campion D, Crane PK, Baldwin C, Becker T, Gudnason V, Cruchaga C, Craig D, Amin N, Berr C, Lopez OL, De Jager PL, Deramecourt V, Johnston JA, Evans D, Lovestone S, Letenneur L, Hernández I, Rubinsztein DC, Eiriksdottir G, Sleegers K, Goate AM, Fiévet N, Huentelman MJ, Gill M, Brown K, Kamboh MI, Keller L, Barberger-Gateau P, McGuinness B, Larson EB, Myers AJ, Dufouil C, Todd S, Wallon D, Love S, Rogaeva E, Gallacher J, George-Hyslop PS, Clarimon J, Lleo A, Bayer A, Tsuang DW, Yu L, Tsolaki M, Bossù P, Spalletta G, Proitsi P, Collinge J, Sorbi S, Garcia FS, Fox NC, Hardy J, Naranjo MC, Bosco P, Clarke R, Brayne C, Galimberti D, Scarpini E, Bonuccelli U, Mancuso M, Siciliano G, Moebus S, Mecocci P, Zompo MD, Maier W, Hampel H, Pilotto A, Frank-García A, Panza F, Solfrizzi V, Caffarra P, Nacmias B, Perry W, Mayhaus M, Lannfelt L, Hakonarson H, Pichler S, Carrasquillo MM, Ingelsson M, Beekly D, Alvarez V, Zou F, Valladares O, Younkin SG, Coto E, Hamilton-Nelson KL, Gu W, Razquin C, Pastor P, Mateo I, Owen MJ, Faber KM, Jonsson PV, Combarros O, O’Donovan MC, Cantwell LB, Soininen H, Blacker D, Mead S, Mosley TH Jr, Bennett DA, Harris TB, Fratiglioni L, Holmes C, de Bruijn RF, Passmore P, Montine TJ, Bettens K, Rotter JI, Brice A, Morgan K, Foroud TM, Kukull WA, Hannequin D, Powell JF, Nalls MA, Ritchie K, Lunetta KL, Kauwe JS, Boerwinkle E, Riemenschneider M, Boada M, Hiltunen M, Martin ER, Schmidt R, Rujescu D, Dartigues JF, Mayeux R, Tzourio C, Hofman A, Nöthen MM, Graff C, Psaty BM, Haines JL, Lathrop M, Pericak-Vance MA, Launer LJ, Van Broeckhoven C, Farrer LA, van Duijn CM, Ramirez A, Seshadri S, Schellenberg GD, Amouyel P, Williams J. PLoS One. 2014 Jun 12;9(6):e94661.

PDF

I.F.:  3,73

doi: 10.1371/journal.pone.0094661. eCollection 2014

 

Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial. Höglinger GU1, Huppertz HJ, Wagenpfeil S, Andrés MV, Belloch V, León T, Del Ser T; TAUROS MRI Investigators. Mov Disord. 2014 Apr;29(4):479-87.

I.F.: 5,634

Boada M, Lafuente A citades com a “collaborators”

Epub 2014 Jan 31.

(de la web de la revista 2014)

doi: 10.1002/mds.25815.

 

Methylglyoxal Produced by Amyloid-β Peptide-Induced Nitrotyrosination of Triosephosphate Isomerase Triggers Neuronal Death in Alzheimer’s Disease. Tajes M, Eraso-Pichot A, Rubio-Moscardó F, Guivernau B, Ramos-Fernández E, Bosch-Morató M, Guix FX, Clarimón J, Miscione GP, Boada M, Gil-Gómez G, Suzuki T, Molina H, Villà-Freixa J, Vicente R, Muñoz FJ. J Alzheimers Dis. 2014 Jan 1;41(1):273-88.

I.F. 3,612

doi: 10.3233/JAD-131685.

On-line: 2014 Mar 10

 

Valoración de las funciones visuoperceptivas yvisuoespaciales en la práctica forense. Ortega G, Alegret M, Espinosa A, Ibarria M, Cañabate P, Boada M. Rev Esp Med Legal. 2014;40:83-5.

PDF

I.F.: 0,22

 

Approaching allelic probabilities and Genome-Wide Association Studies from beta distributions. J. Santiago García-Cremades, Ángel del Río, José A. García, Javier Gayán, Antonio González-Pérez, Agustín Ruiz, Oscar Sotolongo-Grau, Manuel Ruiz-Marín. arXiv:1402.6151 [q-bio.GN] 25 feb 2014.

PDF

I.F.: n/a

 

Follow up of loci from the International Genomics of Alzheimer’s Disease Project identifies TRIP4 as a novel susceptibility gene. Ruiz A, Heilmann S, Becker T, Hernández I, Wagner H, Thelen M, Mauleón A, Rosende-Roca M, Bellenguez C, Bis JC, Harold D, Gerrish A, Sims R, Sotolongo-Grau O, Espinosa A, Alegret M, Arrieta JL, Lacour A, Leber M, Becker J, Lafuente A, Ruiz S, Vargas L, Rodríguez O, Ortega G, Dominguez MA; IGAP, Mayeux R, Haines JL, Pericak-Vance MA, Farrer LA, Schellenberg GD, Chouraki V, Launer LJ, van Duijn C, Seshadri S, Antúnez C, Breteler MM, Serrano-Ríos M, Jessen F, Tárraga L, Nöthen MM, Maier W, Boada M, Ramírez A. Transl Psychiatry. 2014 Feb 4;4:e358.

PDF

I.F.: 4,36

doi: 10.1038/tp.2014.2.

 

Posttranslational Nitro-Glycative Modifications of Albumin in Alzheimer’s Disease: Implications in Cytotoxicity and Amyloid-β Peptide Aggregation. Ramos-Fernández E, Tajes M, Palomer E, Ill-Raga G, Bosch-Morató M, Guivernau B, Román-Dégano I, Eraso-Pichot A, Alcolea D, Fortea J, Nuñez L, Paez A, Alameda F, Fernández-Busquets X, Lleó A, Elosúa R, Boada M, Valverde MA, Muñoz FJ. J Alzheimers Dis. 2014 Jan 1;40(3):643-57.

I.F.:  3,612

doi: 10.3233/JAD-130914

On line: 2014 Feb 06


 

 

2013

 

Impact Factor (JCR 2012): 118,89                                                                             Total pub.: 19

 

 

ATP5H/KCTD2 locus is associated with Alzheimer’s disease risk. Boada M, Antúnez C, Ramírez-Lorca R, Destefano AL, González-Pérez A, Gayán J, López-Arrieta J, Ikram MA, Hernández I, Marín J, Galán JJ, Bis JC, Mauleón A, Rosende-Roca M, Moreno-Rey C, Gudnasson V, Morón FJ, Velasco J, Carrasco JM, Alegret M, Espinosa A, Vinyes G, Lafuente A, Vargas L, Fitzpatrick AL; for the Alzheimer’s Disease Neuroimaging Initiative, Launer LJ, Sáez ME, Vázquez E, Becker JT, López OL, Serrano-Ríos M, Tárraga L, van Duijn CM, Real LM, Seshadri S, Ruiz A. Mol Psychiatry. 2014 Jun;19(6):682-7.

PDF

I.F.: 14,897

PMID: 23857120

DOI: 10.1038

e-pub sep 13

 

Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation. Suárez-Calvet M, Dols-Icardo O, Lladó A, Sánchez-Valle R, Hernández I, Amer G, Antón-Aguirre S, Alcolea D, Fortea J, Ferrer I, van der Zee J, Dillen L, Van Broeckhoven C, Molinuevo JL, Blesa R, Clarimón J, Lleó A. J Neurol Neurosurg Psychiatry. 2014 Jun;85(6):684-91

I.F.: 4,924 (2012)

doi: 10.1136/jnnp-2013-305972.

e-pub des 13

 

Design of a comprehensive Alzheimer’s disease clinic and research center in Spain to meet critical patient and family needs. Boada M, Tárraga L, Hernández I, Valero S, Alegret M, Ruiz A, Lopez OL, Becker JT; Fundació ACE Alzheimer Research Center and Memory Clinic. Alzheimers Dement. 2014 May;10(3):409-15.

PDF

I.F.:  14,483 (2012)

doi: 10.1016/j.jalz.2013.03.006.

pii: S1552-5260(13)00133-7.

e-pub jul 13

 

Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia. Dols-Icardo O, García-Redondo A, Rojas-García R, Sánchez-Valle R, Noguera A, Gómez-Tortosa E, Pastor P, Hernández I, Esteban-Pérez J, Suárez-Calvet M, Antón-Aguirre S, Amer G, Ortega-Cubero S, Blesa R, Fortea J, Alcolea D, Capdevila A, Antonell A, Lladó A, Muñoz-Blanco JL, Mora JS, Galán-Dávila L, Rodríguez De Rivera FJ, Lleó A, Clarimón J. Hum Mol Genet. 2014 Feb 1;23(3):749-54.

PDF

I.F.:  7,692 (2012)

doi: 10.1093/hmg/ddt460.

Epub 2013 Sep 20.

 

Assessing the Role of the Trem2 P.R47h Variant as a Risk Factor for Alzheimer’s Disease and Frontotemporal Dementia. Ruiz A, Dols-Icardo O, Bullido MJ, Pastor P, Rodríguez-Rodríguez E, López de Munain A, de Pancorbo MM, Pérez-Tur J, Alvarez V, Antonell A, López-Arrieta J, Hernández I, Tárraga L, Boada M, Lleó A, Blesa R, Frank-García A, Sastre I, Razquin C, Ortega-Cubero S, Lorenzo E, Sánchez-Juan P, Combarros O, Moreno F, Gorostidi A, Elcoroaristizabal X, Baquero M, Coto E, Sánchez-Valle R, Clarimón J; dementia genetic Spanish consortium (DEGESCO). Neurobiol Aging. 2014 Feb;35(2):444.e1-4.

I.F.:  4.853

doi: 10.1016/j.neurobiolaging.2013.08.011.

e-pub sep 13

 

Identification of Misdiagnosed Fronto-Temporal Dementia using APOE Genotype and Phenotype-Genotype Correlation Analyses. Hernández I, Mauleón A, Rosende-Roca M, Alegret M, Vinyes G, Espinosa A, Sotolongo-Grau O, Becker JT, Valero S, Tárraga L, López OL, Ruiz A, Boada M. Curr Alzheimer Res. 2014 Feb;11(2):182-91

I.F.:  3,676

PMID: 24359501

e-pub des 13

 

Genetic analysis of candidate SNPs for metabolic syndrome in obstructive sleep apnea (OSA). Grilo A, Ruiz-Granados ES, Moreno-Rey C, Rivera JM, Ruiz A, Real LM, Sáez ME. Gene. 2013 May 25;521(1):150-4.

PDF

I.F.:  2.196

doi: 10.1016/j.gene.2013.03.024. Epub 2013

 

Cut-off Scores of a brief Neuropsychological Battery (NBACE) for Spanish Individual adults older than 44 years old. Alegret M, Espinosa A, Valero S, Vinyes-Junqué G, Ruiz A, Hernández I, Rosende-Roca M, Mauleón A, Becker JT, Tárraga L, Boada M. PLoS One. 2013 Oct 16;8(10):e76436.

PDF

I.F.: 3.73

doi: 10.1371

 

Meta-analysis of 74,538 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, Jun G, Destefano AL, Bis JC, Beecham GW, Grenier-Boley B, Russo G, Thornton-Wells TA, Jones N, Smith AV, Chouraki V, Thomas C, Ikram MA, Zelenika D, Vardarajan BN, Kamatani Y, Lin CF, Gerrish A, Schmidt H, Kunkle B, Dunstan ML, Ruiz A, Bihoreau MT, Choi SH, Reitz C, Pasquier F, Hollingworth P, Ramirez A, Hanon O, Fitzpatrick AL, Buxbaum JD, Campion D, Crane PK, Baldwin C, Becker T, Gudnason V, Cruchaga C, Craig D, Amin N, Berr C, Lopez OL, De Jager PL, Deramecourt V, Johnston JA, Evans D, Lovestone S, Letenneur L, Morón FJ, Rubinsztein DC, Eiriksdottir G, Sleegers K, Goate AM, Fiévet N, Huentelman MJ, Gill M, Brown K, Kamboh MI, Keller L, Barberger-Gateau P, McGuinness B, Larson EB, Green R, Myers AJ, Dufouil C, Todd S, Wallon D, Love S, Rogaeva E, Gallacher J, St George-Hyslop P, Clarimon J, Lleo A, Bayer A, Tsuang DW, Yu L, Tsolaki M, Bossù P, Spalletta G, Proitsi P, Collinge J, Sorbi S, Sanchez-Garcia F, Fox NC, Hardy J, Naranjo MC, Bosco P, Clarke R, Brayne C, Galimberti D, Mancuso M, Matthews F; European Alzheimer’s Disease Initiative (EADI); Genetic and Environmental Risk in Alzheimer’s Disease (GERAD); Alzheimer’s Disease Genetic Consortium (ADGC); Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE), Moebus S, Mecocci P, Del Zompo M, Maier W, Hampel H, Pilotto A, Bullido M, Panza F, Caffarra P, Nacmias B, Gilbert JR, Mayhaus M, Lannfelt L, Hakonarson H, Pichler S, Carrasquillo MM, Ingelsson M, Beekly D, Alvarez V, Zou F, Valladares O, Younkin SG, Coto E, Hamilton-Nelson KL, Gu W, Razquin C, Pastor P, Mateo I, Owen MJ, Faber KM, Jonsson PV, Combarros O, O’Donovan MC, Cantwell LB, Soininen H, Blacker D, Mead S, Mosley TH Jr, Bennett DA, Harris TB, Fratiglioni L, Holmes C, de Bruijn RF, Passmore P, Montine TJ, Bettens K, Rotter JI, Brice A, Morgan K, Foroud TM, Kukull WA, Hannequin D, Powell JF, Nalls MA, Ritchie K, Lunetta KL, Kauwe JS, Boerwinkle E, Riemenschneider M, Boada M, Hiltunen M, Martin ER, Schmidt R, Rujescu D, Wang LS, Dartigues JF, Mayeux R, Tzourio C, Hofman A, Nöthen MM, Graff C, Psaty BM, Jones L, Haines JL, Holmans PA, Lathrop M, Pericak-Vance MA, Launer LJ, Farrer LA, van Duijn CM, Van Broeckhoven C, Moskvina V, Seshadri S, Williams J, Schellenberg GD, Amouyel P. Nat Genet. 2013 Dec;45(12):1452-8.

PDF

I.F.: 35.209

doi: 10.1038/ng.2802. Epub 2013 Oct 27.

 

Blood amyloid beta levels in healthy, Mild Cognitive Impairment and Alzheimer’s disease individuals: replication of diastolic blood pressure correlations and analysis of critical covariates. Agustín Ruiz, Pedro Pesini, Ana Espinosa, Virginia Pérez-Grijalba, Sergi Valero, Oscar Sotolongo-Grau, Montserrat Alegret, Inmaculada Monleón, Asunción Lafuente, Mar Buendía, Marta Ibarria, Susana Ruiz; Isabel Hernández; Itziar San José, Lluís Tárraga, Mercè Boada, Manuel Sarasa. PLoS One. 2013 Nov 27;8(11):e81334.

PDF

I.F.: 3.73

doi:10.1371/journal.pone.0081334

 

Rare variants in Calcium homeostasis modulator 1 (CALHM1) gene found in early onset Alzheimer’s disease patients alter calcium homeostasis. Rubio-Moscardo F, Setó-Salvia N, Pera M, Bosch-Morató M, Plata C, Belbin O, Gené G, Dols-Icardo O, Ingelsson M, Helisalmi S, Soininen H, Hiltunen M, Giedraitis V, Lannfelt L, Frank A, Bullido MJ, Combarros O, Sánchez-Juan P, Boada M, Tárraga L, Pastor P, Pérez-Tur J, Baquero M, Molinuevo JL, Sánchez-Valle R, Fuentes-Prior P, Fortea J, Blesa R, Muñoz FJ, Lleó A, Valverde MA, Clarimón J. PLoS One. 2013 Sep 17;8(9):e74203.

PDF

I.F.:  3.73

PMID: 24069280 PMCID: PMC3775809 DOI: 10.1371 –

 

Utilidad de la Lista de Palabras de la Wechsler Memory Scale-III para valorar la memoria episódica verbal en la evaluación forense. Alegret M, Espinosa A, Ibarria M, Cañabate P, Boada M. Rev Esp Med Legal. 2013;39:78-81.

PDF

I.F.: n/a

(0.12 aprox; 2013)

 

Atenció a persones amb demència i la seva família. Cañabate P; Moreno M; Cerdán M. Revista de Treball Social. Col·legi Oficial de Treball Social de Catalunya, abril 2013, nº 198, pàgines 92-97. ISSN 0212-7210.

PDF

I.F.:  n/a

PMID: n/a

DOI: n/a

 

Tsallis entropy approach to radiotherapy treatments. Sotolongo-Grau O, Rodriguez-Perez D, Sotolongo-Costa O, Antoranz JC. Physica A: Statistical Mechanics and its Applications, Volume 392, Issue 9, 1 May 2013, Pages 2007-2015, ISSN 0378-4371

PDF

I.F.:  1,676

 

Single-Domain Amnestic Mild Cognitive Impairment Identified by Cluster Analysis Predicts Alzheimer’s Disease in the European Prospective DESCRIPA Study. Damian M, Hausner L, Jekel K, Richter M, Froelich L, Almkvist O, Boada M, Bullock R, De Deyn PP, Frisoni GB, Hampel H, Jones RW, Kehoe P, Lenoir H, Minthon L, Olde Rikkert MGM, Rodriguez G, Scheltens P, Soininen H, Spiru L, Touchon J, Tsolaki M, Vellas B, Verhey FRJ, Winblad B, Wahlund LO, Wilcock G, Visser PJ. Dement Geriatr Cogn Disord 2013;36:1-19

PDF

I.F.: 2.787

DOI:10.1159/000348354

 

A longitudinal follow-up of 550 Mild Cognitive Impairment patients: evidence for large conversión to dementia rates and detection of major risk factors involved. Espinosa A, Alegret M, Valero S, Vinyes-Junqué G, Hernández I, Mauleón A, Rosende-Roca M, Ruiz A, López O, Tárraga L, Boada M. J Alzheimers Dis. 2013 Jan 1;34(3):769-80.

PDF ResearchGate

I.F.:  4.174

 

Several Direct and Calculated Biomarkers from the Amyloid-β Pool in Blood are Associated with an Increased Likelihood of Suffering from Mild Cognitive Impairment. Pérez-Grijalba V, Pesini P, Monleón I, Boada M, Tárraga L, Ruiz-Laza A, Martínez-Lage P, San-José I, Sarasa M. J Alzheimers Dis. 2013 Jan 1;36(1):211-9

I.F.:  4.174

PMID: 23635404

DOI 10.3233/JAD-121744

 

Transdermal is better than oral: observational research of the satisfaction of caregivers of patients with Alzheimer’s disease treated with rivastigmine. Boada M, Arranz FJ. Dement Geriatr Cogn Disord. 2013;35(1-2):23-33

I.F.:  2.787

 

Genetic Study of Neurexin and Neuroligin Genes in Alzheimer’s Disease. Martínez-Mir A, González-Pérez A, Gayan J, Antúnez C, Marin J, Boada M, López-Arrieta, JK, Fernández E, Ruiz A, Gómez Scholl F, Real LM. J Alzheimers Dis. 2013;35(2):403-12

PDF ResearchGate

I.F.:  4.179

doi: 10.3233/JAD-122257.


 

 

2012

 

Impact Factor (JCR 2011): 51,54                                                               Total pub.: 15

 

Exploratory analysis of seven Alzheimer’s disease genes: disease progression. Ruiz A, Hernández I, Rosende-Roca M, González-Pérez A, Rodríguez-Noriega E, Ramírez-Lorca R, Mauleón A, Moreno-Rey C, Boswell L, Tune L, Valero S, Alegret M, Gayán J, Becker JT, Real LM, Tárraga L, Ballard C, Terrin ML, Sherman S, Payami H, López OL, Mintzer JE, Boada M. Neurobiol Aging. 2013 Apr;34(4):1310.e1-7.

PDF

I.F.:  6.19

PMID: 23036585

 

Progression of Alzheimer disease in Europe: Data from the ICTUS study. Vellas B, Hausner L, Frölich L, Cantet C, Gardette V, Reynish E, Gillette S, Agüera-Morales E, Auriacombe S, Boada M, Bullock R, Byrne J, Camus V, Cherubini A, Eriksdotter-Jönhagen M, Frisoni GB, Hasselbalch S, Jones RW, Martinez-Lage P, Rikkert MO, Tsolaki M, Ousset PJ, Pasquier F, Ribera-Casado JM, Rigaud AS, Robert P, Rodriguez G, Salmon E, Salva A, Scheltens P, Schneider A, Sinclair A, Spiru L, Touchon J, Zekry D, Winblad B, Andrieu S. Curr Alzheimer Res. 2012 Oct 1;9(8):902-12.

I.F.:  3.95

 

Reliable Measurements of the β-Amyloid Pool in Blood Could Help in the Early Diagnosis of AD. Pesini P, Pérez-Grijalba V, Monleón I, Boada M, Tárraga L, Martínez-Lage P, San-José I, Sarasa M. Int J Alzheimers Dis. 2012;2012:604141. Epub 2012 Aug 16.

PDF

I.F.:  n/a

doi: 10.1155/2012/604141.

PMID: 22957297; PMCID: PMC3431090

 

Investigation of C9orf72 in 4 Neurodegenerative Disorders. Xi Z, Zinman L, Grinberg Y, Moreno D, Sato C, Bilbao JM, Ghani M, Hernández I, Ruiz A, Boada M, Morón FJ, Lang AE, Marras C, Bruni A, Colao R, Maletta RG, Puccio G, Rainero I, Pinessi L, Galimberti D, Morrison KE, Moorby C, Stockton JD, Masellis M, Black SE, Hazrati LN, Liang Y, van Haersma de With J, Fornazzari L, Villagra R, Rojas-Garcia R, Clarimón J, Mayeux R, Robertson J, St George-Hyslop P, Rogaeva E. Arch Neurol. 2012 Sep 10:1-8.

PDF

I.F.:  6,19

doi: 10.1001/archneurol.2012.2016.

PMID: 22964832

 

Efficacy of Souvenaid in Mild Alzheimer’s Disease: Results from a Randomized, Controlled Trial. Scheltens P, Twisk JW, Blesa R, Scarpini E, von Arnim CA, Bongers A, Harrison J, Swinkels SH, Stam CJ, de Waal H, Wurtman RJ, Wieggers RL, Vellas B, Kamphuis PJ. J Alzheimers Dis, 31 (2012) 225-236.

I.F.:  4,26

Boada M.: Contributor

 

Molecular evaluation of human Ubiquilin 2 gene PXX domain in familial Frontotemporal dementia patients. Hernández I, Espinosa A, Real LM, Galán JJ, Mauleón A, Roca MR, Tárraga L, Ruiz A, Boada M. J Neurol. 2012 Nov;259(11):2488-90.

I.F.:  3.47

PMID: 22729385

 

La investigación en los procedimientos de incapacidad de las personas con enfermedades neurodegenerativas que cursan con demencia. Josep Arimany-Manso, Esperanza L. Gómez-Durán, Mercè Boada, Silvia Ventura Mas, Lluís Tárraga, Dolors Clos Masó y Jorge Matías-Guiu. Rev Esp Med Legal. 2012;38(3):89-90

PDF

I.F.:  0.22

 

Expansion mutation in C9ORF72 does not influence plasma progranulin levels in frontotemporal dementia. Dols-Icardo O, Suárez-Calvet M, Hernández I, Amer G, Antón-Aguirre S, Alcolea D, Fortea J, Boada M, Tárraga L, Blesa R, Lleó A, Clarimón J. Neurobiol Aging. 33 (2012) 1851.e17-1951.e.19.

PDF ResearchGate

I F: 6,19

PMID: 22502998

 

A Two-Year Follow-Up of Cognitive Deficits and Brain Perfusion in Mild Cognitive Impairment and Mild Alzheimer’s Disease. Alegret M, Cuberas-Borrós G, Vinyes-Junqué G, Espinosa A, Valero S, Hernández I, Roca I, Ruíz A, Rosende-Roca M, Mauleón A, Becker JT, Castell-Conesa J, Tárraga L, Boada M. J Alzheimers Dis. 29 (2012) 1–12

PDF

I.F.:  4.26

PMID: 22406443

 

LMN diet, rich in polyphenols and polyunsaturated fatty acids, improves mouse cognitive decline associated to aging and Alzheimer`s disease. Fernández-Fernández L, Comes G, Bolea I, Valente T, Ruiz J, Murtra P, Ramirez B, Anglés N, Reguant J, Morelló JR, Boada M, Hidalgo J, Escorihuela RM, Unzeta M. Behav Brain Res. 2012 Mar 17;228(2):261-71.

I.F.:  3.39

doi: 10.1016/j.bbr.2011.11.014.

PMID: 22119712

Epub 2011 Nov 22

 

A pilot study of the effects of internet-based cognitive stimulation on neuropsychological function in HIV disease. Becker JT., Dew MA, Aizenstein HJ., López OL, Morow L, Saxton J, Tárraga L. Disabil Rehabil. 2012;34(21):1848-52. Epub 2012 Mar 30.

PDF

I.F.:  1.49

doi: 10.3109/09638288.2012.667188.

PMID: 22458375

 

MMP-2/MMP-9 plasma level and brain expression in CAA-associated hemorrhagic stroke. Hernandez-Guillamon M, Martinez-Saez E, Delgado P, Domingues-Montanari S, Boada C, Penalba A, Boada M, Pagola J, Maisterra O, Rodriguez-Luna D, Molina CA, Rovira A, Alvarez-Sabin J, Ortega-Aznar A, Montaner J. Brain Pathol. 2012 Mar;22(2):133-41.

PDF

I.F.:  4.99

doi: 10.1111/j.1750-3639.2011.00512.x.

PMID: 21707819

 

Plasma β-amyloid levels in Cerebral Amyloid Angiopathy-associated hemorrhagic stroke. Hernández-Guillamon M, Delgado O, Penalba A, Rodríguez-Luna D, Molina CA, Rovira A, Álvarez-Sabin J, Boada M, Montanter J. Neurodegener Dis. 2012;10(1-4):320-3. Epub 2012 Jan 17.

I.F.:  3.06

doi: 10.1159/000333811.

PMID:22261638

 

Normative data of a brief Neuropsychological Battery for Spanish Individuals Older than 49. Alegret M, Espinosa A, Vinyes-Junqué G, Valero S, Hernández I, Tárraga L, Becker JT, Boada M. J Clin Exp Neuropsychol. 2012;34(2):209-1.

PDF

I.F.:  1.80

doi: 10.1080/13803395.2011.630652.

PMID: 22149440 PMCID: PMC3264764 [Available on 2013/2/1]

Epub 2011 Dec 13.

 

Cognitive plasticity in normal and pathological aging. Fernández-Ballesteros R, Botella J, Zamarrón MD, Molina MA, Cabras E, Schettini R, Tárraga L. Clin Interv Aging. 2012;7:15-25. doi: 10.2147/CIA.S27008. Epub 2012 Jan 4.

PDF

I.F.:  2.08

doi: 10.2147/CIA.S27008.

PMID: 22291469; PMCID: PMC3267402


 

2011

 

Impact Factor (JCR 2010): 42,93                                                Total pub.: 9

 

Do Instrumental Activities of Daily Living Predict Dementia at 1- and 2-Year Follow-Up? Findings from the Development of Screening Guidelines and Diagnostic Criteria for Predementia Alzheimer’s Disease Study. Sikkes SA, Visser PJ, Knol DL, de Lange-de Klerk ES, Tsolaki M, Frisoni GB, Nobili F, Spiru L, Rigaud AS, Frölich L, Rikkert MO, Soininen H, Touchon J, Wilcock G, Boada M, Hampel H, Bullock R, Vellas B, Pijnenburg YA, Scheltens P, Verhey FR, Uitdehaag BM. J Am Geriatr Soc 59:2273–2281, 2011

I.F.: 3,98

 

No evidence of APP point mutations and locus duplication in individuals with cerebral amyloid angiopathy. Domingues-Montanari S, Parés M, Hernández-Guillamon M, Fernández-Cadenas I, Mendioroz M, Ortega G, Boada M, Masjuan J, Huertas N, Alvarez-Sabín J, Delgado P, Montaner J; Stroke Project of Cerebrovascular Diseases Study Group, Spanish Society of Neurology. Eur J Neurol. 2011 Oct;18(10):1279-81.

I.F.:  3.69

 

Evaluación de la conveniencia del cambio de vía de administración de Rivastigmina en pacientes con enfermedad de Alzheimer. Blesa R, Boada M, Martínez C, Gil-Saladié D, Antúnez C, Gobatt AL, Grupo KAPA.. Neurologia.2011; 26 :262-71 – vol.26 núm 05

PDF

I.F.:  0.79

 

Genetic association of CR1 polymorphism rs3818361 in Alzheimer’s disease. Antúnez C , Boada M, López-Arrieta J, Moreno-Rey C, Hernández I, Marín J, Gayán J, González-Pérez A, Real LM, Alegret M, Tárraga L, Ramírez-Lorca R, Ruiz A, and the Alzheimer’s Disease Neuroimaging Initiative. Alzheimers Dement. 2011 Jul;7(4):e124-9.

I.F.:  6.37

 

The MTHFD1L gene rs11754661 marker is not associated with Alzheimer’s disease: evidence from a sample of the Spanish population. Ramírez-Lorca R, Boada M, Antúnez C, López-Arrieta J, Moreno-Rey, Hernández I,  Juan Marín J, Gayán J, González-Pérez A, Alegret M, Tárraga L, Real L.M.,  Ruiz A. J Alzheimers Dis. 2011 Jan;25(1):47-50.

PDF ResearchGate

I.F.:  4,26

 

Activation of PKR Causes Amyloid ß-Peptide Accumulation Via De-Repression of BACE1 Expression. Ill-Raga G, Palomer E, Wozniak MA, Ramos-Fernández E, Bosch-Morató M, Tajes M, Guix FX, Galán JJ, Clarimón J, Antúnez C, Real LM, Boada M, Itzhaki RF, Fandos C, Muñoz FJ. PLoS One. 2011;6(6):e21456.

PDF

I.F.:  4.09

 

The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer’s Disease. Antúnez C, Boada M, González-Pérez A, Gayán J, Ramírez-Lorca R, Marín J, Hernández I, Moreno-Rey C, Morón FJ, López-Arrieta J, Mauleón A, Rosende-Roca M, Noguera-Perea F, Legaz-García A, Vivancos-Moreau L, Velasco J, Carrasco JM, Alegret M, Antequera-Torres M, Manzanares S, Romo A, Blanca I, Ruiz S, Espinosa A, Castaño S, García B, Martínez-Herrada B, Vinyes G, Lafuente A, Becker JT, Galán JJ, Serrano-Ríos M; Alzheimer’s Disease Neuroimaging Initiative, Vázquez E, Tárraga L, Sáez ME, López OL, Real LM, Ruiz A. Genome Med. 2011 May 31;3(5):33.

PDF

I.F.:  5.25

 

Clinical features and APOE genotype of pathologically proven early-onset Alzheimer’s disease. Balasa M, Gelpi E, Antonell A, Rey MJ, Sánchez-Valle R, Molinuevo JL, Lladó A; Neurological Tissue Bank/University of Barcelona/Hospital Clínic NTB/UB/HC Collaborative Group. Neurology 2011;76:1-1.

I.F.: 8.31

  1. Boada, I.Herrnández I A.Mauleón (Fundació ACE) coinvestigadoras de este trabajo.

 

ACE variants and risk of intracerebral hemorrhage recurrence in amyloid angiopathy. Domingues-Montanari S, Hernandez-Guillamon M, Fernandez-Cadenas I, Mendioroz M, Boada M, Munuera J, Rovira A, Maisterra O, Parés M, Gutierrez M, Alvarez-Sabin J, Chacón P, Delgado P, Montaner J; Stroke Project Cerebrovascular Diseases Study Group, Spanish Society of Neurology. Neurobiol Aging. 2011 Mar;32(3):551.e13-22.

I.F.: 6,19


 

2010

 

Impact Factor (JCR 2009): 67,03                                               Total pub.: 11

 

Estrogen receptor alpha gene variants are associated with Alzheimer’s disease. Boada M, Antunez C, López-Arrieta J, Caruz A, Moreno-Rey C, Ramírez-Lorca R, Morón FJ, Hernández I, Mauleón A, Rosende-Roca M, Martínez-Lage P, Marín J, Tárraga L, Alegret M, Pedrajas JR, Urda N, Royo JL, Saez ME, Gayán J, González-Pérez A, Real LM, Ruiz A, Galán JJ. Neurobiol Aging. 2012 Jan;33(1):198.e15-24. Epub 2010 Jul 31.

I.F.:  6.19

doi: 10.1016/j.neurobiolaging.2010.06.016.

PMID: 20674091

e-pub jul 10

 

CALHM86L Polymorphism is a Genetic Modifier of Age at Onset in Alzheimer’s disease : A Meta-Analysis Study. Lambert JC, Sleegers K, González-Pérez A, Ingelsson M, Beecham GW, Hiltunen M, Combarros O, Bullido MJ, Brouwers N, Bettens K, Berr C, Pasquier F, Richard F, Dekosky ST, Hannequin D, Haines JL, Tognoni G, Fiévet N, Dartigues JF, Tzourio C, Engelborghs S, Arosio B, Coto E, De Deyn P, Del Zompo M, Mateo I, Boada M, Antunez C, Lopez-Arrieta J, Epelbaum J, Schjeide BM, Frank-Garcia A, Giedraitis V, Helisalmi S, Porcellini E, Pilotto A, Forti P, Ferri R, Delepine M, Zelenika D, Lathrop M, Scarpini E, Siciliano G, Solfrizzi V, Sorbi S, Spalletta G, Ravaglia G, Valdivieso F, Vepsäläinen S, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossù P, Hanon O, Piccardi P, Annoni G, Mann D, Marambaud P, Seripa D, Galimberti D, Tanzi RE, Bertram L, Lendon C, Lannfelt L, Licastro F, Campion D, Pericak-Vance MA, Soininen H, Van Broeckhoven C, Alpérovitch A, Ruiz A, Kamboh MI, Amouyel P. J Alzheimers Dis 2010; 22(1):247-255.

PDF

I.F.:  4,26

 

Matrix metalloproteinase 2 (MMP-2) degrades soluble vasculotropic amyloid-beta E22Q and L34V mutants, delaying their toxicity for human brain microvascular endothelial cells. Hernandez-Guillamon M, Mawhirt S, Fossati S, Blais S, Pares M, Penalba A, Boada M, Couraud PO, Neubert TA, Montaner J, Ghiso J, Rostagno A. J Biol Chem. 2010 Aug 27;285(35):27144-58

PDF

I.F.:  4.77

 

Regional variation on the presentation of AD patients in memory clinics within Europe – data from the ICTUS study. Hausner L, Frölich L., Gardette V, Reynish E, Ousset PJ, Andrieu S2), Vellas B, on behalf of the ICTUS-EADC study group. J Alzheimers Dis. 2010 Jan;21(1):155-65.

I.F.:  4,26

 

Brain perfusion correlates of visuoperceptual deficits in preclinical and mild Alzheimer disease. Alegret M, Vinyes-Junqué G, Boada M, Martínez-Lage P, Cuberas G, Espinosa A, Roca I, Hernández I, Valero S, Rosende-Roca M, Mauleón A, Becker JT, Tárraga L.  J Alzheimers Dis 21 (2010) 557-567.

I.F.:  4,26

 

Albúmina en la plasmaféresis: una nueva terapia de movilización del beta amiloide en la enfermedad de Alzheimer. Boada M.  Rev Neurol 2010;50 (Supl. 5):S9-S18]

Free full text

I.F.:  0.65

 

Willingness-to-pay for reductions in care need: estimating the value of informal care in Alzheimer’s disease. Gustavsson A, Jönsson L, McShane R, Boada M, Wimo A, Zbrozek AS. Int J Geriatr Psychiatry 2010;25:622-632.

I.F.:  2.41

 

Genome-wide Analysis of Genetic Loci Associated With Alzheimer’s Disease.Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, Bis JC, Smith AV, Carassquillo MM, Lambert JC, Harold D, Schrijvers EM, Ramirez-Lorca R, Debette S, Longstreth WT Jr, Janssens AC, Pankratz VS, Dartigues JF, Hollingworth P, Aspelund T, Hernandez I, Beiser A, Kuller LH, Koudstaal PJ, Dickson DW, Tzourio C, Abraham R, Antunez C, Du Y, Rotter JI, Aulchenko YS, Harris TB, Petersen RC, Berr C, Owen MJ, Lopez-Arrieta J, Varadarajan BN, Becker JT, Rivadeneira F, Nalls MA, Graff-Radford NR, Campion D, Auerbach S, Rice K, Hofman A, Jonsson PV, Schmidt H, Lathrop M, Mosley TH, Au R, Psaty BM, Uitterlinden AG, Farrer LA, Lumley T, Ruiz A, Williams J, Amouyel P, Younkin SG, Wolf PA, Launer LJ, Lopez OL, van Duijn CM, Breteler MM; CHARGE Consortium; GERAD1 Consortium; EADI1 Consortium. JAMA. 2010 May 12;303(18):1832-40.

PDF

I.F.:  30.03

 

CALHM1 P86L polymorphism is associated to late-onset Alzheimer’s disease in a recessive model. Boada M, Antúnez C, López-Arrieta J, Galán JJ, Morón FJ, Hernández I, Marín J, Martínez-Lage P, Alegret M, Carrasco JM, Moreno C, Real LM, González-Pérez A, Tárraga L, Ruiz A. J Alzheimers Dis. 2010 Apr;20(1):247-51.

I.F.: 4,261

 

Diagnóstico y evolución de la degeneración lobular fronto-temporal en una unidad de demencias: 12 años de experiencia. Hernández I, Martínez-Lage P, Valero S, Alegret M, Rey MJ, Espinosa A, Mauleón A, Viñas G, Rosende-Roca M, Tárraga L, Boada M.  Alzheimer Real Invest Demenc 2010;44:5-14.

PDF

I.F.:  n/a

 

Genetic screening of Alzheimer’s disease genes in Iberian and African samples yields novel mutations in presenilins and APP. Guerreiro RJ, Baquero M, Blesa R, Boada M, Brás JM, Bullido MJ, Calado A, Crook R, Ferreira C, Frank A, Gómez-Isla T, Hernández I, Lleó A, Machado A, Martínez-Lage P, Masdeu J, Molina-Porcel L, Molinuevo JL, Pastor P, Pérez-Tur J, Relvas R, Oliveira CR, Ribeiro MH, Rogaeva E, Sa A, Samaranch L, Sánchez-Valle R, Santana I, Tàrraga L, Valdivieso F, Singleton A, Hardy J, Clarimón J. Neurobiol Aging. 2010 May;31(5):725-731.

PDF

I.F.:  5,94


 

2009

Impact Factor (JCR 2008): 51,64                                                Total pub.: 11

 

Health and nutritional promotion program for patients with dementia (NutriAlz Study): rando and baseline data.Salva A, Andrieu S, Fernandez E, Schiffrin EJ, Moulin J, Decarli B, Guigoz Y, Vellas B; NutriAlz Group. J Nutr Health Aging. 2009 Jun;13(6):529-37.

PDF ResearchGate

I.F.:  2.68

 

Amyloid-targeted in Alzheimer’s Disease: Use of human albumin in plasma Exchange as a novel approach for Aβ mobilization. Boada M, Ortiz P, Anaya F, Hernández I, Muñoz J, Núñez L, Olazarán J, Roca I, Cuberas G, Tárraga L, Buendia M, Pla RP, Ferrer I, Páez A. Drug News Perspect  2009, 22(6): 325.

PDF

I.F.: 2,20

 

Creating a transatlantic research enterprise for preventing Alzheimer’s disease. Khachaturian ZS, Camí J, Andrieu S, Avila J, Boada M, Breteler M, Froelich L, Gauthier S, Gómez-Isla T, Khachaturian AS, Kuller LH, Larson EB, Lopez OL, Martinez-Lage JM, Petersen RC, Schellenberg GD, Sunyer J, Vellas B, Bain LJ. Alzheimer’s & Dementia 5 (2009) 361-366.

PDF

I.F.:  6.37

 

Long-Term Follow-Up of Patients Immunized with AN1792: Reduced Functional Decline in Antibody Responders. Vellas B, Black R, Thal LJ, Fox NC, Daniels M, McLennan G, Tompkins C, Leibman C, Pomfret M, Grundman M; AN1792 (QS-21)-251 Study Team. Current Alzheimer Research, 2009, 6, 144-151.

PDF

I.F.: 4,97

 

Detection of visuoperceptual deficits in preclinical and mild Alzheimer’s disease. Alegret M, Boada-Rovira M, Vinyes-Junqué G, Valero S, Espinosa A, Hernández I, Modinos G, Rosende-Roca M, Mauleón A, Becker JT, Tárraga L. J Clin Exp Neuropsychol 2009, 31(7), 860-867.

PDF

I.F.: 1,77

 

Neuronal TIMP-1 release accompanies astrocytic MMP-9 secretion and enhances astrocyte proliferation induced by B-amyloid 25-35 fragment. Hernández-Guillamon M, Delgado P, Ortega L, Pares M, Rosell A, García-Bonilla L, Fernández-Cadenas I, Borrell-Pagès M, Boada M, Montaner J. Journal of Neuroscience Research 87:2115-2125(2009).

I.F.: 2,99

 

Safety and efficacy of galantamine (Reminyl) in severe Alzheimer’s disease (the SERAD study): a randomised, placebo-controlled, Double-blind Trial. Burns A, Bernabei R, Bullock R, Cruz Jentoft AJ, Frölich L, Hock C, Raivio M, Triau E, Vandewoude M, Wimo A, Came E, Van Baelen B, Hammond GL, van Oene JC, Schwalen S., The Serad investigators group. Lancet Neurol 2009; 8:39-47.

PDF

I.F.: 18,13

 

Ecological assessment of executive functions in Mild Cognitive Impairment and mild Alzheimer’s Disease. Espinosa A, Alegret M, Boada M, Vinyes G, Valero S, Martínez-Lage P, Peña-Casanova J, Becker JT, Wilson BA, Tárraga L. J Int Neuropsych Soc 2009;15(5): 751–757.

PDF

I.F.:  2,77

 

GAB2 gene does not modify of Alzheimer’s disease in Spanish APOE e4 carriers. Ramírez-Lorca R, Boada M, Sáez M E, Hernández I, Mauleón A, Rosende-Roca M, Martínez-Lage P, Gutiérrez M, Real LM, López-Arrieta J, Gayán J, Antúnez C, González-Pérez A, Tárraga L, Ruiz A. J Nutr Health Aging. 2009 Mar;13(3):214-9.

I.F.: 1,71

 

A diet enriched in polyphenols and polyun saturated fatty acids, LMN diet, induces neurogenesis in the subventricular zone and hippocampus of adult mouse brain. Valente T, Hidalgo J, Bolea I, Ramirez B, Anglés N, Reguant J, Morelló JR, Gutiérrez C, Boada M, Unzeta M. J Alzheimers Dis. 18 (2009) 849-865.

PDF ResearchGate

I.F.: 4,26

 

Prefrontal córtex volume reduction on MRI in preclinical Huntington’s disease relates to visuomotor performance and CAG number. Gómez-Ansón B, Alegret M, Muñoz E, Monté GC, Alayrach E, Sánchez A, Boada M, Tolosa E. Parkinsonism Relat Disord (2009), Volume 15, Issue 3, Pages 213-219

I.F.:  3.79


 

2008

 

Impact Factor (JCR 2007): 30,13                                Total pub.: 9

 

Safety and efficacy of galantamine in subjects with mild cognitive impairment. Winblad B, Gauthier S, Scinto L, Feldman H, Wilcock GK, Truyen L, Mayorga AJ, Wang D, Brashear HR, Nye JS, GAL-INT-11/18 Study Group. Neurology 2008 May 27;70(22):2024-35.

I.F.:  8.31

 

Multi-Center Comparison of Medial Temporal Atrophy in Patients with Alzheimer’s Disease – Data from the ICTUS Study. Galluzzi S, Talassi E, Belussi M, Scheltens P, van de Pol L, Nobili F, Rodriguez G, Froelich L, Damian M, Martinez-Lage P, Gomez-Isla T, Reynish E, Ousset PJ, Vellas B, Frisoni GB. Dement Geriatr Cogn Disord 2008;26:314-322.

I.F.:  2.14

 

EADC (European Alzheimer Disease Consortium) Recommendations for future Alzheimer Disease research in Europe. Winblad B, Frisoni GB, Frolich L, Johannsen P, Johansson G, Kehoe P, Lovestone S, Olde-Rikkert M, Reynish E, Visser PJ, Vellas B, and other executive committee members. The Journal of Nutrition. Health & Aging. Volume 12, Number 10, 2008. Editorial.

I.F.:  2.69

 

Development of screening guidelines and clinical criteria for predementia Alzheimer’s disease. Visser PJ, Verhey FRJ, Boada M, Bullock R, Frisoni G.B., Frölich, L, Hampel H, Jolles J, Minthon L, Nobili F,  Olde Rikkert M, Ousset P.J., Riguad A.S., Scheltens P, Soininen H, Spiru L, Touchon J, Tsolaki, M, Vellas B, Wahlund L.O., Wilcok G, Einblad DESCRIPA study group. Neuroepidemiology 2008;30;254-265

PDF

I.F.:  2.30

 

The Atorvastatin/Donepezil in Alzheimer’s Disease Study (LEADe): Design and baseline characteristics. Jones RW, Kivipelto M, Feldman H, Sparks L, Doody R, Waters DD, Hey-Hadavi J, Breazna A, Schindler RJ, Ramos H; LEADe investigators. Alzheimer’s & Dementia 4 (2008) 145-153.

I.F.:  6.373

 

P53 phosphorylation is involved in vascular cell death induced by de catalytic activity of membrane-bound SSAO/VAP-1. Solé M, Hernández-Guillamon Mar, Boada Mercè, Unzeta Mercedes.  Biochim Biophys Acta. 2008 Jun;1783(6):1085-94.

PDF

I.F.:  2.93

 

A Randomized, Double-Blind, Placebo Controlled-Trial of Triflusal in Mild Cognitive Impairment: the TRIMCI study. Gómez-Isla T, Blesa R1, Boada M, Clarimón J, Domenech G, Ferro JM, Gómez-Ansón B, Manubens JM, Martínez-Lage JM, Muñoz D, Peña J, Torres F, on behalf of the TRIMCI study group.  Alzheimer Disease & Associated Disorders 2008;22:21-29.

I.F.: 2.81

 

The usefulness of standard neuropsychological testing for adults with Down syndrome and dementia. Boada M, Alegret M, Buendia M, Hernández I, Viñas G, Espinosa A, Lara S, Guitart M, Tárraga L. SD International Medical Review on Down Syndrome. 2008;12(1) 2-7

PDF

 

Evidence of depressive symptoms in fragile-X premutated females. Rodríguez-Revenga L, Madrigal I, Alegret M, Santos M, Milá M. Psychiatr Genet 2008;18(4):153-5.

I.F.:  2.58


 

2007

 

Impact Factor (JCR 2007): 25,39                                Total pub.: 6

 

Gene-environment interactions with cognition in late life and compression of morbidity. Becker JT, Tárraga L, Ziolko S, Lopez OL. Am J Psychiatry. 2007 Jun;164(6):849-52.

I.F.: 12.54

PMID: 17541039

 

The ICTUS Study: A Prospective longitudinal observational study of 1,380 AD patients in Europe. Study design and baseline characteristics of the cohort. Reynish E, Cortes F, Andrieu S, Cantet C, Olde Rikkert M, Melis R, Froelich L, Frisoni GB, Jönsson L, Visser PJ, Ousset PJ, Vellas B; ICTUS Study Group. Neuroepidemiology. 2007;29(1-2):29-38

I.F.: 2.30

 

Sodium bicarbonate enhances membrane-bound and soluble human semicarbazide-sensitive amine oxidase activity in vitro. Hernández-Guillamon M, Bolea I, Solé M, Boada M, Tipton KF, Unzeta M, J Biochem. 2007 Nov;142(5):571-6.

PDF ResearchGate

I.F.: 2.37

 

Semicarbazide sensitive Amine Oxidase (SSAO) and its possible contribution to vascular damage in Alzheimer’s disease. Unzeta M, Solé M, Boada M, Hernández M.. J Neural Transm. 2007;114(6):857-62.

PDF ResearchGate

I.F.: 2.73

 

Characterization of A7r5 cell line transfected in a stable form by hSSAO/VAP-1 gene (A7r5 hSSAO/VAP-1 cell line). Solé M, Hernandez M, Boada M and Unzeta M. J Neural Transm (2007) 114:763-767.

PDF ResearchGate

I.F.: 2,73

 

Aquaporin expresión in the cerebral cortex is increased at early stages of Alzheimer’s disease. Pérez, E., Borrachina, M., Rodríguez, A, Boada. M, Ferrer, I. Brain Research 1128 (2007) 164-174.

I.F.: 2,72


 

2006                                                                     Total pub.: 6

 

Propuesta para un registro clínico de demencias. S. López-Pousa, J. Garre-Olmo, S. Montserrat-Vila, M. Boada-Rovira, L. Tárraga-Mestre, M. Aguilar-Barberá, R. Lozano.Fernández de Pinedo, J. Lorenzo-Ferrer. Neurología 2006; 43(1):32-38

PDF

 

Ecological assessment of executive functions in Mild Cognitive Impairment and mild Alzheimer’s Disease. Ana Espinosa, Montserrat Alegret, Mercè Boada, Georgina Vinyes, Sergi Valero, Pablo Martínez-Lage, Jordi Peña-Casanova, James T Becker, Barbara A. Wilson,  Lluís TárragaJournal of the International Neuropsychological Society (JINS) 2009;15(5): 751–757

PDF

 

Relationship between the efficacy of rivastigmine and apolipoprotein E (e4) in patients with mild to moderately severe Alzheimer’s Disease. Blesa R, Aguilar M, Peña J, Boada M, Martínez S, Alom J, Hernández C, Sancho J, Fernández O, Gil E, Martí JF, Alzheimer Dis Assoc Disorder 2006; 20(4): 248-254

 

Validación española de la Behavioural Pathology in Alzheimer’s Disease Rating Scale (BEHAVE-AD). Boada M, Tárraga L, Modinos G, Diego S, Reisberg B. Neurología 2006; 21(1):19-25.

 

Soluble Semicarbazide Sensitive Amine Oxidase (SSAO) catálisis induces apoptosis on vascular smooth muscle cells. Hernández M, Solé M, Boada M, Unzeta M.  Biochimica Biophysica Acta 2006, Feb 1763(2):164-73

PDF

 

A randomised pilot study to assess the efficacy of an interactive, multimedia tool of cognitive stimulation in Alzheimer’s disease. Tárraga L, Boada M, Modinos G, Espinosa A, Diego S, Morera A, Guitart M, Balcells J, López OL, Becker JT. J Neurol Neurosurg Psychiatry. 2006 Oct;77(10):1116-21. Epub 2006 Jul 4.

PDF


 

2005                                                                     Total pub.: 6

 

Etude sur la qualité de la vue chez les adultes porteuses d’un syndrome de Down. Castañé M, Boada M, Hernández I, Journal de la Trisomie 21 2005; 14 :16-21

 

Estudio clinicoterapéutico de la demencia en las personas con síndrome de Down y eficacia del donepecilo en esta población. Boada-Rovira M, Hernández-Ruiz I, Badenas-Homiar S, Buendía-Torras M, Tárraga-Mestre, L. Revista de Neurología, 2005; Vol. 41(3): 129-136.

Free full text

 

Human plasma semicarbazide sensitive amine oxidase (SSAO) b-Amyloid protein and aging. Hernández M, Esteban M, Szabo P, Boada M, Unzeta M. Neurosciences Letters. 2005; 384:183-187

 

Neuropsychiatric Inventory-Nursing Home Version (NPI-NH): Validación española. Boada M, Tárraga L, Modinos G, López OL, Cummings JL, Neurología 2005;20(10): 665-673

PDF

 

Clinical effects of Ab immunization (AN1792) in patients with Alzheimer Disease in an interrupted trial. Gilman S, Koller M, Black RS, Jenkins L, Griffith SG, Fox NC, Eisner L, Kirby L, Boada M, Forette F, Orgogozo JM; for the AN1792(QS-21)-201 Study team. Neurology 2005;64:1553-62.

PDF

 

Effects of Ab immunization (AN1792) on MRI measures of cerebral volume in Alzheimer Disease. Fox NC, Black RS, Gilman S, Rossor MN, Griffith SG, Jenkins L, Koller M; for the AN1792(QS-21)-201 Study team. Neurology 2005; 64: 1563-1572.

PDF


 

2004                                                                    Total pub.: 9

 

El documento de voluntades anticipadas y la relación neurólogo-paciente. Boada Rovira M. Neurología 2004;19(Supl 4):52-59.

PDF

 

Lo que cuestan las demencias. En: Alzheimer 2004: La pragmática necesaria. Boada Rovira, M. Ediciones Aula Médica; 2004:2:13-24.

 

Estudi de la qualitat visual en adults amb síndrome de Down. Castañé M, Boada M, Hernández I. Revista mèdica internacional sobre la Síndrome de Down 2004: vol. 8, núm. 1, pp. 2-7.

PDF

 

Familial Alzheimer disease associated with A713T mutation in APP. Armstrong J, Boada M, Rey MJ, Vidal N, Ferrer I. Neuroscience Letters 2004 370: 241-243.

 

Neuropathology and Pathogenetics of encephalitis following Amyloid-b Immunization in Alzheimer’s Disease. Ferrer I, Boada M, Sánchez ML, Rey MJ, Costa-Jussá F. Brain Pathology 2004 Jan; 14(1):11-20.

 

Trastornos oculares propios del Síndrome de Down en mayores de 40 años. Castañé M., Boada M., Hernández I. Revista de Neurología 2004; 39(11):1017-1021.

Free full text

 

Demencia Senil y Enfermedad de Alzheimer. En: Manual de recomendaciones nutricionales en pacientes geriátricos. Boada Rovira, M., Planas Vilà M. Editores Médicos, S.A.; 2004: 121-128.

 

Micronutrient supplementation in mild Alzheimer disease patients. Planas M., Conde M., Audivert S., Pérez-Portabella C., Burgos R., Chacón P., Rosselló J., Boada M., Tárraga Ll. Clinical Nutrition, 2004; 23:265-272.

 

Efficacy and Safety of Donepezil in Patients with Alzheimer’s Disease. Results of a Global, Multinational, Clinical Experience Study. Boada Rovira, M., Brodaty H., Cras P., Baloyannis S., Emre M., 322 Study Group, Zhang R, Bahra R. Drugs Aging 2004; 21(1):43-53.

I.F (2004): 2.072

 


 

2003                                                                     Total pub.: 8

 

Ubiquitin-negative mini-pick-like bodies in the dentate gyrus in P301L Tauopathy. Ferrer I., Hernández I., Puig B., Rey M.J., Ezquerra M., Tolosa E., Boada M. Journal of Alzheimer’s Disease 2003 Dec;5(6):445-54.

 

Las necesidades informativas sobre la salud en internet. Boada Rovira M. (2003). Quark. Ciencia, Medicina, Comunicación y Cultura núm.27:33-35.

Free full text

 

Subacute Meningoencephalitis in a subset of patients with AD after Aß42 immunization Orgogozo JM1, Gilman S, Dartigues JF, Laurent B, Puel M, Kirby LC, Jouanny P, Dubois B, Eisner L, Flitman S, Michel BF, Boada M, Frank A, Hock C.. Neurology 2003; 61:46-54.

PDF

 

Primary Progressive Aphasia as the initial manifestation of corticobasal degeneration and unusual tauoptahies. Ferrer I., Hernández I., Boada M., Llorente A., Rey M.J., Cardozo A., Ezquerra M., Puig B. (2003). Acta Neuropathol 106:419-435.

 

Possible increased risk for Alzheimer’s disease associated with neprilysin gene. Clarimón J, Muñoz FJ, Boada M, Tárraga L, Sunyer J, Bertranpetit J, Comas D (2003). J Neural Transm 110 (6): 651-657.

 

HSP70-2 (HSPA1B) is associated with noncognitive symptoms in late onset Alzheimer’s disease. Clarimón J., Bertranpetit J., Boada M., Tárraga L., Comas D. (2003). Journal of Geriatric Psychatry and Neurology 16 (3) 146-150.

PDF

 

Joint analysis of candidate genes related to Alzheimer’s disease in a Spanish population. Clarimón J, Bertranpetit J, Calafell F, Boada M, Tàrraga L, Comas D (2003). Psychiatric Genetics 13(2):85-90.

PDF

 

Association study between Alzheimer’s disease and different genes involved in Ab biosynthesis, aggregation and degradation: positive results with BACE1. Clarimón J., Bertranpetit J., Calafell F., Boada M., Tárraga L., Comas D (2003). J Neurol 250:956-961.

PDF


 

2002                                                                    Total pub.: 2

 

Neuropsychiatric Inventory Questionnaire (NPI-Q): Validación española  de una forma abreviada del Neuropsychiatric Inventory (NPI). Boada M, Cejudo JC, Tárraga L, López O, Kaufer D. (2002). Neurología, 2002:17(6):317-323.

PDF

 

 

Apolipoprotein E Christchurch in a family with Alzheimer’s disease and altered lipid values. Clarimón J., Vallés M., Boada M., Tárraga L., Bertranpetit J., Comas D. (2002). Alzheimers Rep. 5:17-20.

PDF


 

2001                                                                     Total pub.: 1

 

Estrategias terapéuticas en la enfermedad de Alzheimer: concepto ad continuum. Boada M. (2001). Revista Neurología; 32 (11): 1074 – 1084.


 

2000                                                                     Total pub.: 3

 

Enfermedad de Alzheimer y medicina basada en la evidencia. Dispositivos asistenciales en la enfermedad de Alzheimer desde la perspectiva de la medicina basada en la evidencia. Boada M., (2000). Revista Neurología, Vol. 15. Suplemento 4, 64 – 78.

 

Review of Creutzfeldt-Jakob disease and other prion diseases. Zivkovic S, Boada M, Lopez O. Rev Neurol. 2000 Dec 16-31;31(12):1171-9

 

Hypertrophic pachymeningitis. A review of the histories of two cases and pathological relationship with the Tolosa-Hunt syndrome and the orbital pseudotumor. Bosch J, Ortega-Aznar A, Tintore M, Rio J, Ferreira R, Rubio E, Rovira A, Abilleira S, Mauleon A, Montalban X, Boada M, Codina A . Rev Neurol. 2000 Nov 16-30;31(10):946-51.


 

1999                                                                     Total pub.: 2

 

El tratamiento longitudinal de la enfermedad de Alzheimer. Del envejecimiento a la enfermedad de Alzheimer. Boada, M., Tárraga, L. (1999). Continua Neurológica, vol 1 (1): 82-106.

 

Coste de los servicios de los pacientes en régimen ambulatorio diagnosticados de enfermedad de Alzheimer en España. Boada M, Peña-Casanova J, Bermejo F, Guillén F, Hart WM, Espinosa C, Rovira J. Med Clin (Barc). 1999 Nov 27;113(18):690-5.

PDF


 

1998                                                                     Total pub.: 4

 

El papel de las unidades de diagnóstico y evaluación de los trastornos cognitivos y de la conducta ante el diagnóstico precoz de la enfermedad de Alzheimer. Análisis de 962 casos consecutivos, período 1996-1998 Fundación ACE. Boada, M. (1998). Revista de Neurología, 27 (Supl 1): S5 – S15

 

A neuropsychological and global study of cognitive impairment and dementia (CID) in the catalonian geriatric institutionalized subjects. Comunicació: Boada M, Tárraga L, Monteserín R, Hernández I, Juncà S, Patricio F, Abós-Herrándiz R, Canela-Soler J. Journal of Clinical Epidemiology 1998, Volume 51, Supp, 19S.

 

Estimated cost of Alzheimer’s Disease (AD) in community patients in Spain: Preliminary results. Comunicació: Boada M, Bermejo F, Peña J, Espinosa C, Bayer QF, Hart WM, Soykos SL, Tárraga L, Abós-Herrándiz R, Canela-Soler J. Journal of Clinical Epidemiology 1998, Volume 51, Supp 1, 31S.

 

Terapias blandas: Programa de Psicoestimulación Integral. Alternativa terapéutica para las personas con enfermedad de Alzheimer. L. Tárraga-Mestre. Rev Neurol. 1998;27:51-01


 

1995                                                                     Total pub.: 2

 

Epidemiología de los Trastornos Cognitivos en la Población Geriátrica de los “Casals d’Avis” de Barcelona Ciudad. Boada M, Tarraga L, Monteserin R, Nebot C, Canela J. Rev Neurol. 1995 Jan-Feb;23(119):166-73.

 

Epidemilología de los Trastornos Cognitivos en Población Geriátrica Internada en Centros Socio-Sanitarios de Barcelona Ciudad. Boada M., Tárraga L., Monteserín R., Nebot C., Canela J. (1995). Rev. Neurol. 23 (119): 174-180.


 

1994                                                                     Total pub.: 1

 

Estrategia no farmacologica del deterioro cerebral senil y demencia. Ll. Tárraga Mestre. Medicine 1994; 6:44-53


 

1989                                                                     Total pub.: 2

 

Remission of a case of intraparenchymal neurocysticercosis folowing treatment with praziquantel. Alvarez Sabin J, Espinaca J, Boada M, Codina Puiggros A.  Rev Clin Esp. 1989 Apr;184(7):388.

 

Myclonic encephalopathy caused by bismuth. Gomez Jimenez J. Alvarez J, Boada Rovira M, Codina Puiggros A. Rev Clin Esp. 1989 Mar;184(4):212.


 

1988                                                                     Total pub.: 1

 

Brain metastases from breast cancer may respond to endocrine therapy. Colomer R, Cosos D, Del Campo JM, Boada M, Rubio D. Breast Cancer Res Treat. 1988 Sep;12(1):83-6


 

1987                                                                     Total pub.: 1

 

Creatine kinase BB isoenzyme as a marker of CNS metastases in patients with small-cell lung cancer. Matias-Guiu J, Colomer R, Ruibal A, Bonaventura I, Boada M, Martinez-Vazquez JM. J Clin Oncol. 1987 Jan;5(1):160-1.


 

1986                                                                     Total pub.: 2

 

Myelin basic protein and creatine kinase BB isoenzyme as CSF markers of intracranial tumors and stroke. Matias-Guiu J, Martinez-Vazquez J, Ruibal A, Colomer R, Boada M, Codina A. Acta Neurol Scand. 1986 May;73(5):461-5.

 

Behavior of prostatic specific antigen (PSA) in spinal fluid: its correlation with serum levels. Morote J, Ruibal A, Boada M.  Int J Biol Markers. 1986 May-Aug;1(2):109-10.


 

1984                                                                     Total pub.: 2

 

Iron-deficiency anemia and pseudotumor cerebri. Buenaventura I, Davalos A, Matias-Guiu J, Boada M, Titus F, Codina Puiggros A. Med Clin (Barc). 1984 Feb18;82(6):281

 

Polymyositis associated with cacinoma of the vulva. Almirante Gragera B, Matias-Guiu Guia J, Boada Rovira M.  Rev Clini Esp 1984 Oct 15;175(1):43-4.


 

1983                                                                     Total pub.: 3

 

Cephalic tetanus studied with single fibre EMG. Fernandez JM, Ferrandiz M, Larrea L, Ramio R, Boada M.  J Neurol Neurosurg Psychiatry. 1983 Sep;46(9):862-6.

PDF

 

Transformation of an ischemic infartion into a hemorrhagic one by anticoagulant treatment in a patient with cerebral embolism. Matias-Guiu J, Buenaventura I, Boada M, Davalos A, Codina Puiggros A. Med Clin (Bar). 1983 Oct 29;81(13).598.

 

Transtentorial herniation during an episode of Bruns syndrome. Matias-Guiu J, Buenaventura I, Boada M, Davalos A, Codina Puiggros A.  Med Clin (Barc). 1983 Dec 10;81(19):880-1